Wolfgang Koenig

Q: What Schools Are Affiliated With Wolfgang Koenig

Wolfgang Koenig is affiliated with the following schools: Technical University of Munich, Massachusetts General Hospital, University of Cambridge, Leiden University, University of Leicester, University of Exeter, University of Ulm, University of Freiburg, University of Regensburg

Wolfgang Koenig's AcademicInfluence.com Rankings

Wolfgang Koenig

Philosophy

#3534

World Rank

#5690

Historical Rank

Logic

#1217

World Rank

#1908

Historical Rank

philosophy Degrees

Wolfgang Koenig

Biology

#4429

World Rank

#6599

Historical Rank

Immunology

#188

World Rank

#196

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Wolfgang Koenig Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Wolfgang Koenig's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (2017) (5238)
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (2008) (4914)
Genetic studies of body mass index yield new insights for obesity biology (2015) (3549)
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. (2003) (2963)
C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. (1999) (2025)
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. (2015) (1708)
Large-scale association analysis identifies new risk loci for coronary artery disease (2012) (1507)
New genetic loci link adipose and insulin biology to body fat distribution (2014) (1227)
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. (2003) (1200)
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. (2005) (1195)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. (2019) (1180)
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators (1998) (1064)
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial (2009) (989)
C-reactive protein, fibrinogen, and cardiovascular disease prediction. (2012) (952)
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. (2016) (765)
New loci associated with kidney function and chronic kidney disease (2010) (754)
Increased plasma viscosity during an air pollution episode: a link to mortality? (1997) (714)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial (2017) (713)
Association between C-reactive protein and features of the metabolic syndrome: a population-based study. (2000) (706)
A randomized trial of rosuvastatin in the prevention of venous thromboembolism. (2009) (695)
C-Reactive Protein in the Arterial Intima: Role of C-Reactive Protein Receptor–Dependent Monocyte Recruitment in Atherogenesis (2000) (652)
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies (2012) (646)
Recommendations for the use of cardiac troponin measurement in acute cardiac care. (2010) (619)
C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. (1998) (598)
Mendelian randomization of blood lipids for coronary heart disease (2014) (580)
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture (2013) (568)
Effect of alcohol consumption on systemic markers of inflammation (2001) (567)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial (2017) (558)
The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study (2015) (532)
C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score: Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany (2004) (488)
Cardiovascular Efficacy and Safety of Bococizumab in High‐Risk Patients (2017) (488)
How to use high-sensitivity cardiac troponins in acute cardiac care (2012) (484)
Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels (2011) (476)
From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report (2006) (475)
Darapladib for preventing ischemic events in stable coronary heart disease. (2014) (475)
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol. (2020) (467)
Lipid-related markers and cardiovascular disease prediction. (2012) (457)
Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. (1998) (456)
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions (2019) (423)
Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study. (2001) (417)
Concept, Design and Implementation of a Cardiovascular Gene-Centric 50 K SNP Array for Large-Scale Genomic Association Studies (2008) (416)
Plasma Oxidized Low-Density Lipoprotein, a Strong Predictor for Acute Coronary Heart Disease Events in Apparently Healthy, Middle-Aged Men From the General Population (2005) (415)
Biomarkers of Atherosclerotic Plaque Instability and Rupture (2007) (400)
Air pollution and markers of inflammation and coagulation in patients with coronary heart disease. (2006) (390)
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function (2016) (388)
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (2019) (377)
PPAR Activators as Antiinflammatory Mediators in Human T Lymphocytes: Implications for Atherosclerosis and Transplantation-Associated Arteriosclerosis (2002) (370)
Sex-stratified Genome-wide Association Studies Including 270,000 Individuals Show Sexual Dimorphism in Genetic Loci for Anthropometric Traits (2013) (365)
C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998. (2003) (357)
How to use high-sensitivity cardiac troponins in acute cardiac care. (2013) (345)
Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium (2010) (344)
Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. (2010) (335)
Lipoprotein-Associated Phospholipase A2 Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population: Results From the 14-Year Follow-Up of a Large Cohort From Southern Germany (2004) (333)
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group. (2004) (333)
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. (2020) (331)
Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) (2018) (320)
Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). (2003) (315)
Cardiovascular effects of fine and ultrafine particles. (2005) (314)
Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. (2005) (313)
Fibrin(ogen) in cardiovascular disease: an update (2003) (311)
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia. (2020) (291)
Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. (2000) (290)
Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. (2012) (288)
The Direct Peroxisome Proliferator-activated Receptor Target Fasting-induced Adipose Factor (FIAF/PGAR/ANGPTL4) Is Present in Blood Plasma as a Truncated Protein That Is Increased by Fenofibrate Treatment* (2004) (282)
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. (2012) (282)
Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors (2002) (278)
Air Pollution and Inflammation (Interleukin-6, C-Reactive Protein, Fibrinogen) in Myocardial Infarction Survivors (2007) (275)
Effects of air pollution on blood pressure: a population-based approach. (2001) (274)
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. (2014) (266)
Increases in heart rate during an air pollution episode. (1999) (264)
Lipid‐Reduction Variability and Antidrug‐Antibody Formation with Bococizumab (2017) (262)
Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. (2010) (256)
Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. (2006) (256)
A catalog of genetic loci associated with kidney function from analyses of a million individuals (2019) (252)
From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. (2006) (251)
High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. (2013) (249)
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study (2018) (244)
Antidiabetic PPAR&ggr;-Activator Rosiglitazone Reduces MMP-9 Serum Levels in Type 2 Diabetic Patients With Coronary Artery Disease (2003) (240)
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. (2012) (238)
Sex differences in the relation of body composition to markers of inflammation. (2006) (237)
Lipoprotein-Associated Phospholipase A2 Predicts Future Cardiovascular Events in Patients With Coronary Heart Disease Independently of Traditional Risk Factors, Markers of Inflammation, Renal Function, and Hemodynamic Stress (2006) (231)
Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease (2011) (228)
Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial (2010) (227)
Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. (2005) (224)
Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. (2018) (221)
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial (2014) (221)
Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. (2012) (220)
Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery Disease (2003) (219)
DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases (2016) (215)
Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque (2011) (214)
CUBN is a gene locus for albuminuria. (2011) (214)
The possible role of hemorheology in atherothrombogenesis. (1992) (208)
Global Suppression of IL-6-induced Acute Phase Response Gene Expression after Chronic in Vivo Treatment with the Peroxisome Proliferator-activated Receptor-α Activator Fenofibrate* (2004) (207)
PPARα governs glycerol metabolism (2004) (201)
The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis (2013) (199)
Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein (2004) (194)
Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium (2016) (193)
Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers (2007) (188)
Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. (2006) (186)
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels (2019) (183)
High-Sensitivity Troponin T Concentrations in Acute Chest Pain Patients Evaluated With Cardiac Computed Tomography (2010) (183)
Genome-Wide Association and Functional Follow-Up Reveals New Loci for Kidney Function (2012) (180)
Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). (2005) (179)
Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. (2005) (175)
Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. (2002) (173)
Pioglitazone Reduces Neointima Volume After Coronary Stent Implantation: A Randomized, Placebo-Controlled, Double-Blind Trial in Nondiabetic Patients (2005) (172)
Plasma viscosity and the risk of coronary heart disease: results from the MONICA-Augsburg Cohort Study, 1984 to 1992. (1998) (171)
Uric Acid Levels Are Associated With All-Cause and Cardiovascular Disease Mortality Independent of Systemic Inflammation in Men From the General Population: The MONICA/KORA Cohort Study (2008) (171)
Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998. (2008) (166)
Long-Term Prognosis of Patients With Takotsubo Syndrome. (2018) (164)
Biomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease (2011) (164)
Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study (2009) (159)
Increased Concentrations of C-Reactive Protein and IL-6 but not IL-18 Are Independently Associated With Incident Coronary Events in Middle-Aged Men and Women: Results From the MONICA/KORA Augsburg Case–Cohort Study, 1984–2002 (2006) (158)
Associations of adipokines with asthma, rhinoconjunctivitis, and eczema in German schoolchildren (2009) (156)
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases (2007) (155)
Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci. (2014) (150)
Assessment of omega‐3 carboxylic acids in statin‐treated patients with high levels of triglycerides and low levels of high‐density lipoprotein cholesterol: Rationale and design of the STRENGTH trial (2018) (150)
Current Infection With Helicobacter pylori, but Not Seropositivity to Chlamydia pneumoniae or Cytomegalovirus, Is Associated With an Atherogenic, Modified Lipid Profile (2001) (148)
Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels (2016) (147)
Loci influencing blood pressure identified using a cardiovascular gene-centric array. (2013) (145)
Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial (2017) (144)
[Cystatin C and cardiovascular risk]. (2012) (144)
Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease. (2018) (144)
Cardiovascular Risk Factors Associated With Venous Thromboembolism (2019) (143)
Happy heart syndrome: role of positive emotional stress in takotsubo syndrome (2016) (142)
Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium (2017) (141)
Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987. (2003) (140)
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) (2020) (134)
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. (2011) (133)
Multiethnic Meta-Analysis of Genome-Wide Association Studies in >100 000 Subjects Identifies 23 Fibrinogen-Associated Loci but No Strong Evidence of a Causal Association Between Circulating Fibrinogen and Cardiovascular Disease (2013) (133)
Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks. (2019) (133)
Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille) (2004) (132)
A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry (2017) (132)
Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. (2007) (130)
Haemostatic risk factors for cardiovascular diseases. (1998) (129)
Overweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adults (2006) (129)
PPARalpha governs glycerol metabolism. (2004) (128)
Associations between ambient air pollution and blood markers of inflammation and coagulation/fibrinolysis in susceptible populations. (2014) (127)
Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients. (2019) (127)
Chemokines and Incident Coronary Heart Disease: Results From the MONICA/KORA Augsburg Case-Cohort Study, 1984–2002 (2006) (127)
Population Distributions of C-reactive Protein in Apparently Healthy Men and Women in the United States : Implication for Clinical Interpretation (127)
Association of ankle-brachial index and plaques in the carotid and femoral arteries with cardiovascular events and total mortality in a population-based study with 13 years of follow-up. (2006) (124)
A genome-wide association study identifies three loci associated with mean platelet volume. (2009) (123)
Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population (2005) (123)
Physical Activity and Mortality in Patients With Stable Coronary Heart Disease. (2017) (122)
Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. (2010) (122)
Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men (2003) (121)
Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes (2015) (121)
Differential Expression of Chemokines, Risk of Stable Coronary Heart Disease, and Correlation with Established Cardiovascular Risk Markers (2006) (121)
Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk. (2015) (119)
Inflammation and Coronary Heart Disease: An Overview (2001) (118)
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium (2019) (118)
Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. (2003) (117)
The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? (2000) (117)
Association Between Long-term Exposure to Air Pollution and Biomarkers Related to Insulin Resistance, Subclinical Inflammation, and Adipokines (2016) (113)
Association Between Rheology and Components of Lipoproteins in Human Blood: Results From the MONICA Project (1992) (113)
Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes (2006) (113)
Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study. (2015) (111)
Genetic Association Study Identifies HSPB7 as a Risk Gene for Idiopathic Dilated Cardiomyopathy (2010) (110)
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study (2021) (110)
Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. (2003) (109)
Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes. (2004) (109)
Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. (1999) (108)
Genetic Markers Enhance Coronary Risk Prediction in Men: The MORGAM Prospective Cohorts (2012) (108)
Metabolites associate with kidney function decline and incident chronic kidney disease in the general population. (2013) (107)
Role of novel markers of inflammation in patients with stable coronary heart disease. (2001) (107)
Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers (2005) (106)
Symptoms of anxiety and depression in patients with stable coronary heart disease: prognostic value and consideration of pathogenetic links (2007) (106)
Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case–Cohort Study, 1984–2002 (2008) (105)
Serum metabolite concentrations and decreased GFR in the general population. (2012) (104)
Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts (2014) (104)
Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). (2006) (103)
Leisure-time physical activity but not work-related physical activity is associated with decreased plasma viscosity. Results from a large population sample. (1997) (103)
Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. (2009) (102)
Air Temperature and Inflammatory Responses in Myocardial Infarction Survivors (2008) (102)
Utility of inflammatory markers in the management of coronary artery disease. (2003) (101)
Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial (2018) (101)
Noninvasive assessment of arterial stiffness and risk of atherosclerotic events (2006) (100)
Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies. (2012) (99)
Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study. (2005) (99)
Ambient source-specific particles are associated with prolonged repolarization and increased levels of inflammation in male coronary artery disease patients. (2007) (98)
Inflammation and type 2 diabetes: results from KORA Augsburg. (2005) (97)
Association between Lp-PLA2 and coronary artery disease: focus on its relationship with lipoproteins and markers of inflammation and hemostasis. (2005) (97)
Immunological and Cardiometabolic Risk Factors in the Prediction of Type 2 Diabetes and Coronary Events: MONICA/KORA Augsburg Case-Cohort Study (2011) (96)
Effect of Serum 25-Hydroxyvitamin D on Risk for Type 2 Diabetes May Be Partially Mediated by Subclinical Inflammation (2011) (95)
Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. (2012) (93)
Association of Novel Genetic Loci With Circulating Fibrinogen Levels: A Genome-Wide Association Study in 6 Population-Based Cohorts (2009) (93)
Immune Mediators in Patients With Acute Diabetic Foot Syndrome (2009) (92)
Mediterranean diet and inflammatory response in myocardial infarction survivors. (2009) (92)
Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein. (2005) (91)
Seasonal variations of rheological and hemostatic parameters and acute-phase reactants in young, healthy subjects. (1997) (89)
Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data. (2007) (88)
Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease. (2017) (88)
Associations between leptin and the leptin / adiponectin ratio and incident Type 2 diabetes in middle‐aged men and women: results from the MONICA / KORA Augsburg Study 1984–2002 (2010) (87)
Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria (2019) (86)
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential (2019) (84)
Association Between Cardiovascular Risk Profiles and the Presence and Extent of Different Types of Coronary Atherosclerotic Plaque as Detected by Multidetector Computed Tomography (2008) (83)
Plasma Fibrin D-Dimer Levels and Risk of Stable Coronary Artery Disease: Results of a Large Case-Control Study (2001) (83)
Association between different domains of physical activity and markers of inflammation. (2009) (83)
BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries (2014) (82)
Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis. (2003) (82)
Subclinical Inflammation and Diabetic Polyneuropathy (2009) (82)
Dense Genotyping of Candidate Gene Loci Identifies Variants Associated With High-Density Lipoprotein Cholesterol (2011) (82)
Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial. (2012) (81)
Physical activity, coronary heart disease, and inflammatory response. (2003) (81)
Effect of Evolocumab on Coronary Plaque Composition. (2018) (81)
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. (2013) (80)
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men (1998) (80)
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease. (2017) (80)
Fenofibrate Reduces Atherogenesis in ApoE*3Leiden Mice: Evidence for Multiple Antiatherogenic Effects Besides Lowering Plasma Cholesterol (2006) (78)
Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease (2017) (78)
Secretory Phospholipase A2-IIA and Cardiovascular Disease (2013) (78)
Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA/KORA Augsburg case-cohort study. (2013) (78)
Oxidized LDL and the risk of coronary heart disease: results from the MONICA/KORA Augsburg Study. (2011) (77)
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. (2017) (77)
CD14 C(-260)-->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. (2002) (76)
Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease. (2009) (76)
The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. (2003) (75)
A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. (2016) (75)
Discovery and fine mapping of serum protein loci through transethnic meta-analysis. (2012) (75)
Short-term effects of air pollution: a panel study of blood markers in patients with chronic pulmonary disease (2009) (74)
Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study (2005) (72)
Effect of Chronic Kidney Disease and Comorbid Conditions on Health Care Costs: A 10-Year Observational Study in a General Population (2009) (72)
Cystatin C and cardiovascular risk. (2009) (72)
Vulnerable plaques and patients: state-of-the-art. (2020) (71)
Circulating Levels of Interleukin 1-Receptor Antagonist and Risk of Cardiovascular Disease: Meta-Analysis of Six Population-Based Cohorts (2017) (71)
Association of Subclinical Inflammation With Polyneuropathy in the Older Population (2013) (70)
C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998. (2005) (70)
Air Pollution from Road Traffic and Systemic Inflammation in Adults: A Cross-Sectional Analysis in the European ESCAPE Project (2015) (70)
Effect of Rosiglitazone Treatment on Plaque Inflammation and Collagen Content in Nondiabetic Patients: Data From a Randomized Placebo-Controlled Trial (2006) (70)
Association between the intake of vitamins and trace elements from supplements and C-reactive protein: results of the MONICA/KORA Augsburg study (2008) (70)
Prevalence of non-alcoholic fatty liver and characteristics in overweight adolescents in the general population (2007) (70)
Long-term effects of elemental composition of particulate matter on inflammatory blood markers in European cohorts. (2015) (70)
Effect of Drinking on Adiponectin in Healthy Men and Women (2009) (69)
Transforming growth factor-beta1 and incident type 2 diabetes: results from the MONICA/KORA case-cohort study, 1984-2002. (2009) (69)
Air Pollution and Atherosclerosis: A Cross-Sectional Analysis of Four European Cohort Studies in the ESCAPE Study (2015) (69)
Dietary patterns, subclinical inflammation, incident coronary heart disease and mortality in middle-aged men from the MONICA/KORA Augsburg cohort study (2011) (69)
The cardio-metabolic risk of moderate and severe obesity in children and adolescents. (2013) (69)
The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. (2000) (68)
Cystatin C and Cardiovascular Disease (2016) (68)
Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study (2012) (68)
Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis. (2021) (67)
Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. (2012) (67)
Proinflammatory Cytokines Predict the Incidence and Progression of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study (2017) (66)
Leptin, adiponectin, their ratio and risk of Coronary Heart Disease: results from the MONICA/KORA Augsburg Study 1984-2002. (2010) (66)
Interleukin-6 Signaling Effects on Ischemic Stroke and Other Cardiovascular Outcomes (2019) (66)
Association between social isolation and inflammatory markers in depressed and non-depressed individuals: Results from the MONICA/KORA study (2011) (66)
Fibrinogen and Cardiovascular Risk (1993) (65)
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: A Meta-Analysis of Population-Based Studies Involving 17,180 Individuals. (2019) (65)
Uric acid, type 2 diabetes, and cardiovascular diseases: fueling the common soil hypothesis? (2008) (65)
Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events (2014) (65)
Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study (2013) (65)
Effects of acute psychological stress on glucose metabolism and subclinical inflammation in patients with post-traumatic stress disorder. (2010) (64)
Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome. (2010) (64)
Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years (2015) (63)
Genetic Predictors of Fibrin D-Dimer Levels in Healthy Adults (2011) (63)
Age- and Sex-Specific Causal Effects of Adiposity on Cardiovascular Risk Factors (2015) (62)
Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: negative results of a case-control study. (2000) (62)
Association between plasma viscosity and blood pressure. Results from the MONICA-project Augsburg. (1991) (62)
Prevalence and cluster of cardiometabolic biomarkers in overweight and obese schoolchildren: results from a large survey in southwest Germany. (2008) (62)
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease (2017) (62)
Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) study. (2011) (62)
Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry (2019) (61)
Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. (2008) (61)
Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes (2021) (60)
Epidemiology of chronic kidney disease: results from a population of older adults in Germany. (2009) (60)
Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study. (2008) (59)
High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease (2002) (58)
Plasma Concentrations of Afamin Are Associated With the Prevalence and Development of Metabolic Syndrome (2014) (57)
Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease (2004) (57)
Sfrp5 correlates with insulin resistance and oxidative stress (2013) (56)
Alcohol as a Gastric Disinfectant? The Complex Relationship between Alcohol Consumption and Current Helicobacter pylori Infection (2001) (56)
Genome-Wide Association Study Identifies 3 Genomic Loci Significantly Associated With Serum Levels of Homoarginine: The AtheroRemo Consortium (2013) (56)
Geographical variations in plasma viscosity and relation to coronary event rates (1994) (56)
Association between degenerative aortic valve disease and long-term exposure to cardiovascular risk factors: results of the longitudinal population-based KORA/MONICA survey. (2009) (56)
Myeloperoxidase Production by Macrophage and Risk of Atherosclerosis (2012) (56)
Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV). (2016) (55)
Adaptive servo‐ventilation for central sleep apnoea in systolic heart failure: results of the major substudy of SERVE‐HF (2018) (55)
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. (2007) (55)
Exercise and thrombosis. (2000) (55)
Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. (2006) (55)
Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters. (2002) (54)
Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome. (2019) (54)
Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. (2012) (54)
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies (2009) (54)
Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol. (2004) (54)
Systemic inflammation, genetic susceptibility and lung function (2008) (54)
Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures (2015) (53)
Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo Registry (2019) (53)
Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: the KORA Survey 2000. (2006) (52)
Lipoprotein-Associated and Secretory Phospholipase A2 in Cardiovascular Disease: The Epidemiological Evidence (2009) (52)
Alcohol inflammation and coronary heart disease (2003) (52)
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype. (2011) (52)
Objectively Measured Walking Duration and Sedentary Behaviour and Four-Year Mortality in Older People (2016) (51)
Exercise and thrombosis (2000) (51)
Biomarkers of iron metabolism are independently associated with impaired glucose metabolism and type 2 diabetes: the KORA F4 study. (2015) (51)
Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF. (2015) (51)
Biomarkers of outcome from cardiovascular disease (2006) (50)
How to use C-reactive protein in acute coronary care. (2013) (50)
RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. (2008) (50)
Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies (2018) (49)
Interaction between smoking and the interleukin-6 gene affects systemic levels of inflammatory biomarkers. (2009) (49)
Genotype and Plasma Concentration of Cystatin C in Patients With Coronary Heart Disease and Risk for Secondary Cardiovascular Events (2005) (49)
Modification of the Interleukin-6 Response to Air Pollution by Interleukin-6 and Fibrinogen Polymorphisms (2009) (49)
Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study (2017) (49)
DNA variants, plasma levels and variability of C-reactive protein in myocardial infarction survivors: results from the AIRGENE study. (2008) (49)
Prospective association of vitamin D with frailty status and all-cause mortality in older adults: Results from the KORA-Age Study. (2015) (48)
Comparison of the proximal flow convergence method and the jet area method for the assessment of the severity of tricuspid regurgitation. (1998) (48)
G(−30)A Polymorphism in the Pancreatic Promoter of the Glucokinase Gene Associated With Angiographic Coronary Artery Disease and Type 2 Diabetes Mellitus (2004) (48)
General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 Cohort (2018) (47)
Lack of seasonal variation in C-reactive protein. (2002) (47)
Recommendations for detection of individual risk for comorbidities in patients with psoriasis (2013) (46)
Blood Rheology in Healthy Cigarette Smokers: Results from the MONICA Project, Augsburg (1988) (46)
MASP1, THBS1, GPLD1 and ApoA-IV are novel biomarkers associated with prediabetes: the KORA F4 study (2016) (46)
Prevalence of celiac disease in Germany: a prospective follow-up study. (2013) (46)
Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities (2010) (46)
CRP in Cardiovascular Disease (2009) (46)
Air temperature and inflammatory and coagulation responses in men with coronary or pulmonary disease during the winter season (2009) (45)
Update on C-reactive protein as a risk marker in cardiovascular disease. (2003) (45)
Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism--the Finnish Diabetes Prevention Study. (2011) (45)
Air Pollution and Inflammatory Response in Myocardial Infarction Survivors: Gene–Environment Interactions in a High-Risk Group (2007) (45)
RANTES/CCL5 and Risk for Coronary Events: Results from the MONICA/KORA Augsburg Case-Cohort, Athero-Express and CARDIoGRAM Studies (2011) (45)
Hypoadiponectinemia and Proinflammatory State: Two Sides of the Same Coin? (2006) (45)
Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women (2005) (45)
Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: role of confounding and reference group. (2003) (44)
Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. (2008) (44)
Measures to assess the prognostic ability of the stratified Cox proportional hazards model (2009) (44)
Delivery Mode, Duration of Labor, and Cord Blood Adiponectin, Leptin, and C-Reactive Protein: Results of the Population-Based Ulm Birth Cohort Studies (2016) (44)
C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care. (2013) (44)
Metabolite profiling reveals new insights into the regulation of serum urate in humans (2013) (44)
Vasoregulatory peptides pro-endothelin-1 and pro-adrenomedullin are associated with metabolic syndrome in the population-based KORA F4 study. (2012) (43)
Seasonality of vitamin D status in older people in Southern Germany: implications for assessment. (2013) (43)
Tooth loss is independently associated with poor outcomes in stable coronary heart disease (2016) (43)
Acute-Phase Serum Amyloid A Protein and Its Implication in the Development of Type 2 Diabetes in the KORA S4/F4 Study (2013) (42)
Job strain associated CRP is mediated by leisure time physical activity: Results from the MONICA/KORA study (2012) (42)
Non-conventional markers of atherosclerosis before and after gastric banding surgery. (2009) (42)
Social isolation and depressed mood are associated with elevated serum leptin levels in men but not in women (2011) (42)
Fibrinogen genes modify the fibrinogen response to ambient particulate matter. (2009) (42)
Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors (2015) (42)
Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools (2007) (42)
Association between plasma viscosity and all‐cause mortality: results from the MONICA–Augsburg Cohort Study 1984–92 (2000) (41)
Risk stratification in cardiovascular disease primary prevention – scoring systems, novel markers, and imaging techniques (2012) (41)
Copper, ceruloplasmin, and long-term cardiovascular and total mortality (The Ludwigshafen Risk and Cardiovascular Health Study) (2014) (41)
Cardiovascular Biomarkers: Added Value With an Integrated Approach? (2007) (40)
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. (2021) (40)
Coexistence and outcome of coronary artery disease in Takotsubo syndrome. (2020) (40)
Differential association of adiponectin with cardiovascular risk markers in men and women? The KORA survey 2000 (2007) (40)
Genetic Determinants of Circulating Interleukin-1 Receptor Antagonist Levels and Their Association With Glycemic Traits (2014) (40)
Handgrip strength is inversely and independently associated with multimorbidity among older women: Results from the KORA-Age study. (2016) (40)
Single resting hsTnT level predicts abnormal myocardial stress test in acute chest pain patients with normal initial standard troponin. (2013) (39)
Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention (2020) (39)
Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial. (2021) (39)
Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease (2016) (38)
Drinking modulates monocyte migration in healthy subjects: a randomised intervention study of water, ethanol, red wine and beer with or without alcohol (2008) (38)
The effect of alcohol, tobacco and caffeine consumption and vegetarian diet on gallstone prevalence (2010) (38)
Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach (2007) (38)
Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study (2021) (38)
Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany (2017) (38)
Third generation oral contraceptive use and cardiovascular risk factors. (2004) (38)
Sleep disturbances and depressed mood: A harmful combination associated with increased leptin levels in women with normal weight (2012) (38)
Association of objectively measured physical activity with established and novel cardiovascular biomarkers in elderly subjects: every step counts (2012) (37)
Retinol-Binding Protein 4 Is Associated With Prediabetes in Adults From the General Population (2011) (37)
Prevalence and determinants of chronic kidney disease in community-dwelling elderly by various estimating equations (2012) (37)
Low-density lipoprotein particle diameter and mortality: the Ludwigshafen Risk and Cardiovascular Health Study. (2015) (37)
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) (2020) (37)
Short-term effects of air temperature on blood markers of coagulation and inflammation in potentially susceptible individuals (2012) (37)
Predicting the Risk of Cardiovascular Disease (2012) (37)
C-reactive protein and coronary heart disease. (2004) (37)
Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study (2016) (37)
Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. (2008) (36)
A Variant In the Abo Gene Explains the Variation in Soluble E-Selectin Levels—Results from Dense Genotyping in Two Independent Populations (2012) (36)
Determination of C-reactive protein: comparison of three high-sensitivity immunoassays. (2003) (36)
C-reactive protein (CRP) and long-term air pollution with a focus on ultrafine particles. (2018) (36)
Multi-marker strategy of natriuretic peptide with either conventional or high-sensitivity troponin-T for acute coronary syndrome diagnosis in emergency department patients with chest pain: from the "Rule Out Myocardial Infarction using Computer Assisted Tomography" (ROMICAT) trial. (2012) (36)
Chronic infection with Helicobacter pylori does not provoke major systemic inflammation in healthy adults: results from a large population-based study. (1999) (35)
Association between variations in the TLR4 gene and incident type 2 diabetes is modified by the ratio of total cholesterol to HDL-cholesterol (2008) (35)
Metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus (2017) (35)
Common variants in Mendelian kidney disease genes and their association with renal function. (2013) (35)
Association of low 25-hydroxyvitamin D levels with the frailty syndrome in an aged population: Results from the KORA-Age Augsburg study (2015) (35)
Prediabetes is associated with microalbuminuria, reduced kidney function and chronic kidney disease in the general population: The KORA (Cooperative Health Research in the Augsburg Region) F4-Study. (2017) (35)
Is Inflammation a Causal Chain between Low Socioeconomic Status and Type 2 Diabetes? Results from the KORA Survey 2000 (2005) (35)
Associations between Blood Glucose and Carotid Intima-Media Thickness Disappear after Adjustment for Shared Risk Factors: The KORA F4 Study (2012) (35)
Job Strain–Associated Inflammatory Burden and Long-Term Risk of Coronary Events: Findings from the MONICA/KORA Augsburg Case-Cohort Study (2013) (35)
Atherosclerosis involves more than just lipids : focus on inflammation (1999) (35)
Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993. (1996) (34)
C-Reactive Protein as a Predictor for Incident Diabetes Mellitus Among Middle-aged Men (2003) (34)
Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans (2014) (34)
Environmental tobacco smoke and cardiometabolic risk in young children: results from a survey in south-west Germany. (2009) (34)
Associations of Fatty Liver Disease and Other Factors Affecting Serum SHBG Concentrations: A Population Based Study on 1657 Subjects (2013) (34)
Differential Association Between Biomarkers of Subclinical Inflammation and Painful Polyneuropathy: Results From the KORA F4 Study (2014) (34)
A Systemic Inflammatory Signature Reflecting Cross Talk Between Innate and Adaptive Immunity Is Associated With Incident Polyneuropathy: KORA F4/FF4 Study (2018) (34)
Markers of Inflammation and Weight Change in Middle‐Aged Adults: Results From the Prospective MONICA/KORA S3/F3 Study (2010) (34)
Relation of genetic profile and novel circulating biomarkers with coronary plaque phenotype as determined by intravascular ultrasound: rationale and design of the ATHEROREMO-IVUS study. (2014) (33)
Oral contraceptive use is associated with a systemic acute phase response (1999) (33)
Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease (2018) (33)
Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers (2017) (33)
Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study. (2015) (33)
Prevalence and Predictors of Subclinical Micronutrient Deficiency in German Older Adults: Results from the Population-Based KORA-Age Study (2017) (33)
C-Reactive protein and cardiovascular risk: has the time come for screening the general population? (2001) (33)
Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study (2018) (33)
Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). (2005) (33)
Markers of inflammation in women on different hormone replacement therapies (2003) (32)
Differential associations between blood biomarkers of inflammation, oxidation, and lipid metabolism with varying forms of coronary atherosclerotic plaque as quantified by coronary CT angiography (2010) (32)
Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study (2015) (32)
The Geriatric Nutritional Risk Index predicts increased healthcare costs and hospitalization in a cohort of community-dwelling older adults: results from the MONICA/KORA Augsburg cohort study, 1994-2005. (2011) (32)
Acute-phase reactants and coronary heart disease. (2002) (32)
Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). (2006) (32)
Association between muscular strength and inflammatory markers among elderly persons with cardiac disease: results from the KORA-Age study (2015) (31)
Age-Related Variations in Takotsubo Syndrome. (2020) (31)
The effect of marine n-3 fatty acids in different doses on plasma concentrations of Lp-PLA2 in healthy adults (2009) (31)
Anxiety Associated Increased CpG Methylation in the Promoter of Asb1: A Translational Approach Evidenced by Epidemiological and Clinical Studies and a Murine Model (2017) (31)
Leptin, adiponectin, and short-term and long-term weight loss after a lifestyle intervention in obese children. (2013) (31)
Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease (2003) (31)
Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion. (2016) (31)
Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention? (2018) (30)
Comparison of the Efficacy and Tolerability of Combination Tablets Containing Candesartan Cilexetil and Hydrochlorothiazide or Losartan and Hydrochlorothiazide in Patients with Moderate to Severe Hypertension (2000) (30)
Plasma copeptin is associated with type 2 diabetes in men but not in women in the population-based KORA F4 study (2015) (30)
Activation of the Autonomic Nervous System and Blood Coagulation in Association with an Air Pollution Episode (2000) (30)
Atherosclerosis: Recent trials, new targets and future directions. (2015) (29)
Gestational Weight Gain and Fetal-Maternal Adiponectin, Leptin, and CRP: results of two birth cohorts studies (2017) (29)
Physical activity, coronary heart disease, and inflammatory response☆ (2003) (29)
Growth Differentiation Factor 15, Its 12-Month Relative Change, and Risk of Cardiovascular Events and Total Mortality in Patients with Stable Coronary Heart Disease: 10-Year Follow-up of the KAROLA Study. (2016) (29)
Prevention of cardiovascular disease guided by total risk estimations − challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy (2012) (29)
Strategies for vascular disease prevention: the role of lipids and related markers including apolipoproteins, low-density lipoproteins (LDL)-particle size, high sensitivity C-reactive protein (hs-CRP), lipoprotein-associated phospholipase A2 (Lp-PLA₂) and lipoprotein(a) (Lp(a)). (2014) (29)
Air pollution and liver enzymes. (2013) (29)
C-Reactive Protein Risk Prediction: Low Specificity, High Sensitivity (2002) (29)
Genome-Wide Association Study Identifies Two Novel Regions at 11p15.5-p13 and 1p31 with Major Impact on Acute-Phase Serum Amyloid A (2010) (28)
Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia. (2013) (28)
Comparison of plasma fibrinogen by Clauss, prothrombin time-derived, and immunonephelometric assays in a general population: implications for risk stratification by thirds of fibrinogen (2003) (28)
Prognostic association of HbA1c and fasting plasma glucose with reduced kidney function in subjects with and without diabetes mellitus. Results from a population-based cohort study from Germany. (2013) (27)
Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline. (2020) (27)
Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome: Insights From the International Takotsubo Registry. (2019) (27)
Genetics of type 2 diabetes: impact of interleukin-6 gene variants. (2005) (27)
Lipoprotein-associated phospholipase A2 concentrations in plasma are associated with the extent of coronary artery disease and correlate to adipose tissue levels of marine n-3 fatty acids. (2008) (27)
Catecholamines and the Renin‐Angiotensin‐Aldosterone System During Treatment with Felodipine ER or Hydrochlorothiazide in Essential Hypertension (1991) (27)
Variability of serial lipoprotein-associated phospholipase A2 measurements in post myocardial infarction patients: results from the AIRGENE Study Center Augsburg. (2008) (27)
[Sex specific trends of sudden cardiac death and acute myocardial infarction: results of the population-based KORA/MONICA-Augsburg register 1985 to 1998]. (2002) (27)
Effect of blood glucose concentrations on admission in non-diabetic versus diabetic patients with first acute myocardial infarction on short- and long-term mortality (from the MONICA/KORA Augsburg Myocardial Infarction Registry). (2009) (26)
Relationship of thoracic fat depots with coronary atherosclerosis and circulating inflammatory biomarkers (2015) (26)
Relationship between Inflammatory Cytokines and Uric Acid Levels with Adverse Cardiovascular Outcomes in Patients with Stable Coronary Heart Disease (2012) (26)
Physical activity, muscular strength, and polypharmacy among older multimorbid persons: Results from the KORA‐Age study (2018) (26)
Association of novel metrics of particulate matter with vascular markers of inflammation and coagulation in susceptible populations -results from a panel study. (2016) (26)
Helicobacter pylori heat shock protein 60 and risk of coronary heart disease: a case control study with focus on markers of systemic inflammation and lipids. (2001) (26)
Cholesterol-Lowering Agents. (2019) (26)
Is Increased Plasma Viscosity A Risk Factor for High Blood Pressure? (1989) (26)
Association between dietary inflammatory index, and cause-specific mortality in the MONICA/KORA Augsburg Cohort Study (2018) (26)
Cytomegalovirus infection and coronary heart disease: results of a german case-control study. (1999) (25)
C-reactive protein and atherosclerosis. Is there a causal link? (2003) (25)
Associations between thyroid hormones and serum metabolite profiles in an euthyroid population (2013) (25)
Blood Rheology Associated with Cardiovascular Risk Factors and Chronic Cardiovascular Diseases: Results of an Epidemiologic Cross-sectional Study (1988) (25)
Pregnancy is not a risk factor for gallstone disease: results of a randomly selected population sample. (2005) (25)
Prognostic value of chronic kidney disease in patients with coronary heart disease: role of estimating equations. (2010) (25)
Residual Beta Cell Function in Newly Diagnosed Type 1 Diabetes after Treatment with Atorvastatin: The Randomized DIATOR Trial (2011) (25)
Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population (2009) (25)
Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium. (2019) (25)
Fibrinogen and coronary risk (1999) (24)
DNA variants, plasma levels and variability of interleukin-6 in myocardial infarction survivors: results from the AIRGENE study. (2009) (23)
Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial) (2012) (23)
Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis (2018) (23)
Intervention study shows outpatient cardiac rehabilitation to be economically at least as attractive as inpatient rehabilitation (2009) (23)
Determinants of the acute-phase protein C-reactive protein in myocardial infarction survivors: the role of comorbidities and environmental factors. (2009) (23)
Association of adiponectin and leptin with relative telomere length in seven independent cohorts including 11,448 participants (2014) (23)
Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease. (2017) (23)
Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies. (2020) (23)
Apolipoprotein A-I and risk for cardiovascular diseases (2006) (23)
High-Density Lipoprotein Subclasses, Coronary Artery Disease, and Cardiovascular Mortality. (2017) (23)
Sex differences in selection of pacemakers: retrospective observational study (1998) (23)
Inflammation and Cardiovascular Disease: The Future (2021) (23)
Soluble thrombomodulin as a predictor of type 2 diabetes: results from the MONICA/KORA Augsburg case–cohort study, 1984–1998 (2007) (23)
Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis (2009) (23)
Inflammation Revisited: Atherosclerosis in The Post-CANTOS Era. (2017) (22)
Association between anemia and falls in community-dwelling older people: cross-sectional results from the KORA-Age study (2014) (22)
High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study (2013) (22)
Lifetime physical activity patterns and risk of coronary heart disease (2006) (22)
The influence of the type of occupation on return to work after myocardial infarction, coronary angioplasty and coronary bypass surgery. (1988) (22)
Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project (2020) (22)
Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study (2017) (22)
No evidence for an association of posttraumatic stress disorder with circulating levels of CRP and IL-18 in a population-based study. (2013) (21)
Effects of felodipine ER and hydrochlorothiazide on blood rheology in essential hypertension—a randomized, double‐blind, crossover study (1991) (21)
Insulin resistance, heart disease and inflammation. Identifying the 'at-risk' patient: the earlier the better? The role of inflammatory markers. (2002) (21)
Relationship between electrocardiographic and biochemical variables in coronary artery disease. (2007) (21)
New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk (2014) (21)
Longitudinal associations between ambient air pollution and insulin sensitivity: results from the KORA cohort study. (2021) (21)
Molecular Characterization of the NLRC4 Expression in Relation to Interleukin-18 Levels (2015) (21)
Impact of aspirin on takotsubo syndrome: a propensity score‐based analysis of the InterTAK Registry (2019) (21)
Reproducibility in serial C-reactive protein and interleukin-6 measurements in post-myocardial infarction patients: results from the AIRGENE study. (2010) (21)
Plasma viscosity as a cardiovascular risk factor. (1992) (20)
Low-Grade Inflammation Modifies Cardiovascular Risk Even at Very Low LDL-C Levels: Are We Aiming for a Dual Target Concept? (2018) (20)
Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry. (2018) (20)
Prevalence of the Metabolic Syndrome in Southwest Germany (2005) (20)
Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study (2017) (20)
Reproductive factors, intima media thickness and carotid plaques in a cross-sectional study of postmenopausal women enrolled in the population-based KORA F4 study (2014) (20)
High-Sensitivity Cardiac Troponin I as a Gatekeeper for Coronary Computed Tomography Angiography and Stress Testing in Patients with Acute Chest Pain. (2017) (20)
Ambient Air Pollution and Lipoprotein-Associated Phospholipase A2 in Survivors of Myocardial Infarction (2011) (20)
Association of fetuin-A with incident type 2 diabetes: results from the MONICA/KORA Augsburg study and a systematic meta-analysis. (2018) (20)
Recalibration of the ACC/AHA Risk Score in Two Population-Based German Cohorts (2016) (20)
Correlation of concentrations of high-sensitivity troponin T and high-sensitivity C-reactive protein with plaque progression as measured by CT coronary angiography. (2014) (20)
Type II Secretory Phospholipase A2 and Prognosis in Patients with Stable Coronary Heart Disease: Mendelian Randomization Study (2011) (20)
Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis (2021) (19)
Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy (2020) (19)
Long-term trajectories of anxiety and depression in patients with stable coronary heart disease and risk of subsequent cardiovascular events. (2020) (19)
Prognostic value of inflammatory markers alone and in combination with blood lipids in patients with stable coronary artery disease. (2005) (19)
Association of growth differentiation factor 15 with other key biomarkers, functional parameters and mortality in community-dwelling older adults. (2019) (19)
Genome-Wide Association Study Pinpoints a New Functional Apolipoprotein B Variant Influencing Oxidized Low-Density Lipoprotein Levels But Not Cardiovascular Events: AtheroRemo Consortium (2013) (19)
Objectively measured physical activity and vitamin D status in older people from Germany (2015) (19)
Clinical Predictors and Prognostic Impact of Recovery of Wall Motion Abnormalities in Takotsubo Syndrome: Results From the International Takotsubo Registry (2019) (19)
Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease (2008) (19)
Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease—a comparison in the MONICA/KORA study (2020) (18)
Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample (2014) (18)
Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib. (2020) (18)
Efficacy and Tolerability of Felodipine and Amlodipine in the Treatment of Mild to Moderate Hypertension (1993) (18)
Genetic variation in Fcγ receptor IIa and risk of coronary heart disease: negative results from two large independent populations (2009) (18)
Expression of intercellular adhesion molecule-1 in human coronary endothelial and smooth muscle cells after stimulation with tumor necrosis factor-alpha. (1998) (18)
The genetic variation of the tenomodulin gene (TNMD) is associated with serum levels of systemic immune mediators—the Finnish Diabetes Prevention Study (2008) (18)
The rs1800629 polymorphism in the TNF gene interacts with physical activity on the changes in C-reactive protein levels in the Finnish Diabetes Prevention Study. (2010) (18)
Serum Vitamin D Concentrations and Cognitive Function in a Population-Based Study among Older Adults in South Germany. (2015) (18)
Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation (2015) (18)
Iron Metabolism, Hepcidin, and Mortality (the Ludwigshafen Risk and Cardiovascular Health Study). (2019) (18)
Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study. (2016) (18)
Clinical imaging for prevention: Directed strategies for improved detection of presymptomatic patients with undetected atherosclerosis—Part I: Clinical imaging for prevention (2008) (18)
Coffee consumption and NAFLD: a community based study on 1223 subjects (2015) (17)
Vitamin E supplementation is associated with lower levels of C-reactive protein only in higher dosages and combined with other antioxidants: The Cooperative Health Research in the Region of Augsburg (KORA) F4 study. (2015) (17)
Psychotropic drug utilization patterns in a metropolitan population (2004) (17)
Rosuvastatin for primary prevention in older individuals with high C-reactive protein and low LDL levels: exploratory analysis of a randomized trial (2010) (17)
Association of glycemic status and segmental left ventricular wall thickness in subjects without prior cardiovascular disease: a cross-sectional study (2018) (17)
Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype (2017) (17)
Reduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factors (2011) (17)
Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT Trial. (2010) (17)
Prospective evaluation of renal function, serum vitamin D level, and risk of fall and fracture in community-dwelling elderly subjects (2014) (17)
Identification of Comprehensive Metabotypes Associated with Cardiometabolic Diseases in the Population‐Based KORA Study (2018) (16)
Association study between variants in the fibrinogen gene cluster, fibrinogen levels and hypertension: Results from the MONICA/ KORA study (2009) (16)
Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease. (2015) (16)
Association of Apolipoproteins with Symptoms of Asthma and Atopy among Schoolchildren (2009) (16)
Effect of Serum25-Hydroxyvitamin D on Risk forType2DiabetesMayBePartially Mediated by Subclinical Inflammation Results from the MONICA/KORA Augsburg study (2011) (16)
Myeloperoxidase, superoxide dismutase‐3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study (2018) (16)
Recent progress in the clinical aspects of fibrinogen. (1995) (16)
Frailty index and sex-specific six-year mortality in community dwelling older people - the ActiFE Study. (2019) (16)
Associations between calcium and vitamin D supplement use as well as their serum concentrations and subclinical cardiovascular disease phenotypes. (2015) (16)
Varespladib methyl, an oral phospholipase A2 inhibitor for the potential treatment of coronary artery disease. (2009) (16)
Evaluation of diagnostic relevance of mRNA levels in peripheral blood: predictive value for mortality in hemodialysis patients. (2004) (16)
Myocardial infarction and incidence of type 2 diabetes mellitus. Is admission blood glucose an independent predictor for future type 2 diabetes mellitus? (2010) (16)
Direct enzyme immunometric measurement of plasma big endothelin-I concentrations and correlation with indicators of left ventricular function. (1998) (15)
Oral contraceptive use and blood pressure in a German metropolitan population. (1985) (15)
Systemic low-grade inflammation and risk of coronary heart disease: results from the MONICA/KORA Augsburg cohort studies. (2005) (15)
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome. (2021) (15)
Direct comparisons of three alternative plasma fibrinogen assays with the von Clauss assay in prediction of cardiovascular disease and all‐causes mortality: the Scottish Heart Health Extended Cohort (2013) (15)
Renal Function and Urinary Biomarkers in Cardiac Bypass Surgery: A Prospective Randomized Trial Comparing Three Surgical Techniques (2015) (15)
Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease (2018) (15)
[The myocardial infarct status of a South German population: results of the Augsburg myocardial infarct register l985]. (1988) (15)
Presence and extent of coronary artery disease by cardiac computed tomography and risk for acute coronary syndrome in cocaine users among patients with chest pain. (2009) (15)
Deciphering the Plasma Proteome of Type 2 Diabetes (2020) (15)
Fibrinogen and atherothrombogenesis (1993) (14)
C-reactive protein and cardiovascular risk: an update on what is going on in cardiology. (2003) (14)
Plasma MR-proANP levels are associated with carotid intima-media thickness in the general community: the KORA F4 study. (2013) (14)
Association of humoral immunity to human Hsp60 with the IL-6 gene polymorphism C-174G in patients with type 2 diabetes and controls. (2005) (14)
DNA methylation age is associated with an altered hemostatic profile in a multiethnic meta-analysis. (2018) (14)
Rapid effect of single-dose rosiglitazone treatment on endothelial function in healthy men with normal glucose tolerance: data from a randomised, placebo-controlled, double-blind study (2010) (14)
Metabolomics reveals an entanglement of fasting leptin concentrations with fatty acid oxidation and gluconeogenesis in healthy children (2017) (14)
Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention. (2019) (14)
Plasma insulin levels in childhood are related to maternal factors – results of the Ulm Birth Cohort Study (2014) (14)
Different effects of antisense RelA p65 and NF-κB1 p50 oligonucleotides on the nuclear factor-κB mediated expression of ICAM-1 in human coronary endothelial and smooth muscle cells (2001) (14)
Prediction of short‐ and long‐term mortality in takotsubo syndrome: the InterTAK Prognostic Score (2019) (14)
Long term effects of comprehensive cardiac rehabilitation in an inpatient and outpatient setting. (2011) (14)
Hemorheology, thrombogenesis, and atherosclerosis. (1993) (14)
Regional Variation of Chronic Kidney Disease in Germany: Results From Two Population-Based Surveys (2015) (14)
Influence of Plasma Cortisol and Other Laboratory Parameters on Nonalcoholic Fatty Liver Disease (2014) (13)
Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis (2018) (13)
Prognostic value of one-year course of symptoms of anxiety and depression in patients with coronary heart disease: Role of physical activity and unmet medical need (2015) (13)
Relevance of correction for drift and day-to-day variation in cystatin C measurement: a post-hoc analysis of the PREVEND cohort, with independent replication in the ESTHER cohort (2015) (13)
TGF‐β1 content in atherosclerotic plaques, TGF‐β1 serum concentrations and incident coronary events (2012) (13)
Is hsCRP Back on Board? Implications from the JUPITER Trial. (2009) (13)
Low serum omentin levels in the elderly population with Type 2 diabetes and polyneuropathy (2015) (13)
Mendelian Randomization Analyses for Selection of Therapeutic Targets for Cardiovascular Disease Prevention: a Note of Circumspection (2016) (13)
Safety and Efficacy of Aliskiren/Amlodipine/Hydrochlorothiazide Triple Combination in Patients With Moderate to Severe Hypertension: A 54‐Week, Open‐Label Study (2012) (13)
C-reactive protein and cardiovascular risk in the Framingham Study. (2006) (13)
C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile? (2001) (12)
Leukocyte attack in a 3D human coronary in‐vitro model (2001) (12)
Lp-PLA2 Inhibition—The Atherosclerosis Panacea? (2010) (12)
Multi-state models of transitions in depression and anxiety symptom severity and cardiovascular events in patients with coronary heart disease (2019) (12)
C-Reactive Protein in the Arterial Intima : Role of C-Reactive Protein Receptor (2000) (12)
Left ventricular function and wall thickness in long‐term insulin‐dependent diabetes mellitus: an echocardiographic study (1991) (12)
[Hemorheologic variables in manifest arterial vascular diseases]. (1986) (12)
Association of Insulin-like Growth Factor 1 Concentrations with Risk for and Prognosis of Amyotrophic Lateral Sclerosis – Results from the ALS Registry Swabia (2020) (12)
Meta-analyses identify DNA methylation associated with kidney function and damage (2021) (12)
Epigenetic Signatures at AQP3 and SOCS3 Engage in Low-Grade Inflammation across Different Tissues (2016) (12)
The Systemic Immune Network in Recent Onset Type 1 Diabetes: Central Role of Interleukin-1 Receptor Antagonist (DIATOR Trial) (2013) (12)
Characteristics of differences in Helicobacter pylori serology and 13 C-urea breath-testing in an asymptomatic sample of blood donors (2001) (11)
Vitamin D in Relation to Incident Sarcopenia and Changes in Muscle Parameters Among Older Adults: The KORA-Age Study (2019) (11)
Treating residual cardiovascular risk: will lipoprotein-associated phospholipase A2 inhibition live up to its promise? (2008) (11)
A prospective assessment of cardiac biomarkers for hemodynamic stress and necrosis and the risk of falls among older people: the ActiFE study (2016) (11)
Association Between Visfatin and Hepatic Steatosis in the General Population During Long-Term Follow-Up (2019) (11)
Moderater Alkoholkonsum und Plasmakonzentration sensitiver Entzündungsmarker (2003) (11)
Impact of Atrial Fibrillation on Outcome in Takotsubo Syndrome: Data From the International Takotsubo Registry (2021) (11)
[Moderate alcohol consumption and plasma concentration of sensitive markers of inflammation. Comment on an atheroprotective relationship]. (2003) (11)
Discordance of High-Sensitivity Troponin Assays in Patients With Suspected Acute Coronary Syndromes. (2021) (10)
Metabolic syndrome and the plasma proteome: from association to causation (2021) (10)
Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort study (2022) (10)
Beneficial effects of external muscle stimulation on glycaemic control in patients with type 2 diabetes. (2008) (10)
Angiographic results of a Tacrolimus-eluting stent in acute coronary syndrome lesions (2009) (10)
Determinants of plasma interleukin-6 levels among survivors of myocardial infarction (2008) (10)
Derivation and validation of a sensitive IMA cutpoint to predict cardiac events in patients with chest pain (2009) (10)
The European Collaborative Project on Inflammation and Vascular Wall Remodeling in Atherosclerosis - Intravascular Ultrasound (ATHEROREMO-IVUS) study. (2018) (10)
DNAm-based signatures of accelerated aging and mortality in blood are associated with low renal function (2021) (10)
Incidence Rates of Type 2 Diabetes in People With Impaired Fasting Glucose (ADA vs. WHO Criteria) and Impaired Glucose Tolerance: Results From an Older Population (KORA S4/F4/FF4 Study) (2018) (10)
Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy? (2020) (10)
Measurement of plasma viscosity in stored frozen samples: a general population study (2003) (10)
Soluble thrombomodulin in coronary heart disease: lack of an association in the MONICA/KORA case–cohort study (2011) (10)
Association between type II secretory phospholipase A 2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease (2009) (10)
Plasminogen levels and risk of coronary artery disease. (2002) (9)
Serum uromodulin is inversely associated with the metabolic syndrome in the KORA F4 study (2019) (9)
Refining Long-Term Prediction of Cardiovascular Risk in Diabetes – The VILDIA Score (2017) (9)
Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study (2020) (9)
Leptin in Human Milk and Child Body Mass Index: Results of the Ulm Birth Cohort Studies (2019) (9)
Integrating biomarkers: The new frontier? (2010) (9)
Ultra-sensitive troponin I is an independent predictor of incident coronary heart disease in the general population (2017) (9)
Changes of omentin-1 and chemerin during 4 weeks of lifestyle intervention and 1 year follow-up in children with obesity. (2021) (9)
Ldlr-/- and ApoE-/- mice better mimic the human metabolite signature of increased carotid intima media thickness compared to other animal models of cardiovascular disease. (2018) (9)
Antidepressant combination therapy of endogenous depressions with benzodiazepines or neuroleptics--a study comparing adjuvant treatment with oxazolam versus chlorprothixene. (1988) (9)
DNA methylation signature of chronic low-grade inflammation and its role in cardio-respiratory diseases (2021) (9)
Proinsulin to insulin ratio is associated with incident type 2 diabetes but not with vascular complications in the KORA F4/FF4 study (2020) (9)
Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study. (2020) (9)
Comparison of psychotropic drug intake in two populations in West Germany. Results from the Munich Blood Pressure Study 1980/81 and the Luebeck Blood Pressure Study 1984. (1987) (9)
Assessment of global and regional myocardial function using the Minnesota Q/QS codes. A comparison with clinical ECG interpretation. (1993) (9)
Plasma Proteomics of Renal Function: A Transethnic Meta-Analysis and Mendelian Randomization Study (2021) (9)
No Evidence for Genome-Wide Interactions on Plasma Fibrinogen by Smoking, Alcohol Consumption and Body Mass Index: Results from Meta-Analyses of 80,607 Subjects (2014) (9)
Association of changes in inflammation with variation in glycaemia, insulin resistance and secretion based on the KORA study (2018) (8)
Modifying effect of metabotype on diet–diabetes associations (2019) (8)
Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium (2021) (8)
Serum uromodulin is associated with but does not predict type 2 diabetes in elderly KORA F4/FF4 study participants. (2019) (8)
PLA1A2 platelet polymorphism predicts mortality in prediabetic subjects of the population based KORA S4-Cohort (2014) (8)
Risk Markers of Incident Atrial Fibrillation in Patients with Coronary Heart Disease. (2021) (8)
Fasting time and lipid parameters: association with hepatic steatosis — data from a random population sample (2014) (8)
Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality. (2019) (8)
Serial Measurements of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Coronary Heart Disease (2015) (8)
Accuracy of ECG indices for diagnosis of left ventricular hypertrophy in people >65 years: results from the ActiFE study (2017) (8)
Temporal trends in cardiovascular risk factors and performance of the Framingham Risk Score and the Pooled Cohort Equations (2018) (8)
Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study. (2018) (8)
Association of Subclinical In fl ammation With Polyneuropathy in the Older Population KORA F 4 study (2013) (8)
Protein 4 Is Associated With Prediabetes in Adults From the General Population The Cooperative Research in the Region of Augsburg (KORA) F4 Study (2011) (8)
Association of endothelial dysfunction with incident prediabetes, type 2 diabetes and related traits: the KORA F4/FF4 study (2020) (7)
Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease (2005) (7)
Improved peri-operative risk stratification in non-cardiac surgery: going beyond established clinical scores. (2013) (7)
Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention (2016) (7)
Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death (2020) (7)
Association of lung function with overall mortality is independent of inflammatory, cardiac, and functional biomarkers in older adults: the ActiFE-study (2020) (7)
Prognostic value of midregional pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with stable coronary heart disease followed over 8 years. (2014) (7)
Sex hormone-binding globulin, androgens and mortality: the KORA-F4 cohort study (2020) (7)
Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events: results of a long-term follow-up study in routine clinical care (2013) (7)
Meta-analysis of epigenome-wide association studies of carotid intima-media thickness (2021) (7)
Generalized anxiety disorder symptoms and type 2 diabetes onset: Findings from the Prospective Cooperative Health Research in the Region of Augsburg F4 and FF4 studies. (2021) (7)
Effects of the coronary artery disease associated LPA and 9p21 loci on risk of aortic valve stenosis. (2019) (7)
Discovery and replication of SNP-SNP interactions for quantitative lipid traits in over 60,000 individuals (2017) (7)
Lipoprotein-Associated Phospholipase A 2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease (2016) (7)
Repeat Measurements of High Sensitivity Troponins for the Prediction of Recurrent Cardiovascular Events in Patients With Established Coronary Heart Disease: An Analysis From the KAROLA Study (2019) (7)
Circulating levels of interleukin-18 independent of body fat and fat-free mass: results from the MONICA/KORA study. (2006) (7)
Biomarkers in patients with heart failure and central sleep apnoea: findings from the SERVE‐HF trial (2020) (7)
Cardiac Troponin I and Incident Stroke in European Cohorts (2020) (7)
Intrafamilial associations of cardiometabolic risk factors--results of the Ulm Birth Cohort Study. (2015) (7)
C-reactive protein in the Heart Protection Study (2011) (7)
C-Reactive Protein and Cardiovascular Risk: Will the Controversy End after CANTOS? (2017) (6)
Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry (2021) (6)
Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study. (2016) (6)
Myeloperoxidase, but not oxidized LDL, is associated with leisure-time physical activity: results from the MONICA/KORA Augsburg Studies 1984-1995. (2011) (6)
Serum amyloid P component and cardiovascular disease: is there a sensible link? (2007) (6)
Atrial fibrillation and long-term prognosis of patients with stable coronary heart disease: Relevance of routine electrocardiogram. (2016) (6)
Erratum: Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci (American Journal of Human Genetics (2012) 90 (410-425)) (2012) (6)
Determinants of leptin in human breast milk: results of the Ulm SPATZ Health Study (2018) (6)
Hypoalpha-hyperbeta-lipoproteinemia in a patient with coronary artery disease and occlusive peripheral arterial disease. (1982) (6)
Chronic kidney disease and risk of atrial fibrillation and heart failure in general population‐based cohorts: the BiomarCaRE project (2021) (6)
Serum uromodulin and decline of kidney function in older participants of the population-based KORA F4/FF4 study (2020) (6)
Association of iron deficiency with incident cardiovascular diseases and mortality in the general population (2021) (6)
Serum uromodulin is inversely associated with arterial hypertension and the vasoconstrictive prohormone CT-proET-1 in the population-based KORA F4 study (2020) (6)
Association of Dietary Patterns and Type-2 Diabetes Mellitus in Metabolically Homogeneous Subgroups in the KORA FF4 Study (2020) (6)
Plasma copeptin levels are inversely associated with intima-media-thickness in men: the population-based KORA F4 study (2013) (6)
Ramipril vs Lisinopril in the Treatment of Mild to Moderate Primary Hypertension — A Randomised Double-Blind Multicentre Trial (1992) (6)
Random glucose GWAS in 493,036 individuals provides insights into diabetes pathophysiology, complications and treatment stratification (2021) (6)
Self‐Reported Health and Outcomes in Patients With Stable Coronary Heart Disease (2017) (6)
Immune cell-based cardiovascular risk assessment: spotlight on the neutrophil-lymphocyte ratio. (2021) (5)
Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation. (2019) (5)
Acute inflammation and long-term cardiovascular risk: Identifying an unrecognised vulnerable gap (2017) (5)
Sexual Activity Patterns Before Myocardial Infarction and Risk of Subsequent Cardiovascular Adverse Events. (2015) (5)
Epigenome-wide association study of serum urate reveals insights into urate co-regulation and the SLC2A9 locus (2021) (5)
Neurological outcome after a severe herpes simplex encephalitis treated with acyclovir and β-interferon time course of intracranial pressure (1990) (5)
Morbidity and mortality of myocardial infarction in the MONICA study area Augsburg in 1985 (2005) (5)
Association of Long-Term Air Pollution with Prevalence and Incidence of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study (2020) (5)
Is proteomics of value in cardiovascular risk assessment? (2019) (5)
Genetic variants in the Upstream Stimulatory Factor 1 (USF1) gene are associated with LDL cholesterol levels and incident T2DM in women: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002 (2008) (5)
High-sensitivity troponin T and C-reactive protein to identify patients without cardiac structural and functional abnormalities as assessed by cardiac CT and SPECT imaging: can biomarkers predict cardiac health? (2012) (5)
Impact of White Blood Cell Count on Clinical Outcomes in Patients Treated with Aspirin-Free Ticagrelor Monotherapy after Percutaneous Coronary Intervention: Insights from the GLOBAL LEADERS Trial. (2020) (5)
A Panel of 6 Biomarkers Significantly Improves the Prediction of Type 2 Diabetes in the MONICA/KORA Study Population (2020) (5)
Noninvasive detection of anterior wall asynergies by cardiokymography compared to electrocardiography. (1988) (5)
Transforming Growth Factor-β1 and Incident Type 2 Diabetes (2009) (5)
Clinical correlates and prognostic impact of neurologic disorders in Takotsubo syndrome (2021) (5)
Serum uromodulin is inversely associated with biomarkers of subclinical inflammation in the population-based KORA F4 study (2020) (5)
Phospholipase A2 as a therapeutic target for atherosclerosis (2010) (4)
Efficacy and Tolerability of Felodipine and Amlodipine in the Treatment of Mild to Moderate Hypertension A Randomised Double-Blind Multicentre Trial (4)
Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 (Lp-PLA2) mass and activity: Meta-analysis of genome-wide association studies from five community-based studies (2010) (4)
49. Hyperfibrinogenemia and cardiovascular risk: possible strategies for intervention (1996) (4)
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events. (2020) (4)
Influence of Storage and Inter- and Intra-Assay Variability on the Measurement of Inflammatory Biomarkers in Population-Based Biobanking. (2017) (4)
Critical evaluation of models to identify individuals with insulin resistance. (2005) (4)
Sa.53. Chemokines and Risk of Myocardial Infarction: Results from the Monica/Kora Augsburg Study, 1984–2002 (2006) (4)
[Epidemiology of coronary heart disease]. (1998) (4)
[Atherosclerosis as an Inflammatory Disease - Pathophysiology, Clinical Relevance and Therapeutic Implications]. (2019) (4)
Soluble CD14 concentration in human breast milk and its potential role in child atopic dermatitis: Results of the Ulm Birth Cohort Studies (2018) (4)
Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT (2021) (4)
Targeted proteomics improves cardiovascular risk prediction in secondary prevention (2022) (4)
Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals (2022) (4)
Add-on Immunoadsorption Shortly-after Optimal Medical Treatment Further Significantly and Persistently Improves Cardiac Function and Symptoms in Recent-Onset Heart Failure—A Single Center Experience (2018) (4)
Comparison of a Point-Of-Care Test for High-Sensitivity C-Reactive Protein with an Established Immuno-Nephelometric Method. (2015) (4)
INCLISIRAN AND CARDIOVASCULAR OUTCOMES: ANALYSES FROM ORION-11 (2020) (4)
Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies (2022) (4)
Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy (2019) (4)
Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: design of the VRONI study (2021) (4)
Persistent inflammatory residual risk despite aggressive cholesterol-lowering therapy: further evidence fuelling the dual target concept. (2020) (4)
Hemodynamic effects of alinidine (ST 567) at rest and during exercise in patients with chronic congestive heart failure. (1990) (4)
Sonographically Assessed Intra-Abdominal Fat And Cardiometabolic Risk Factors in Adolescents with Extreme Obesity (2016) (4)
Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial (2019) (4)
[Combined catheterization of the right and left heart by means of transseptal puncture of the left atrium]. (1962) (4)
Felodipine and amlodipine in stable angina pectoris: results of a randomized double-blind crossover trial. (1997) (4)
Therapie der Hypercholesterinämie in der Primärprävention (2019) (4)
Abstract 981: High-Sensitivity Troponin Reliably Excludes Acute Coronary Syndrome in Patients with Acute Chest Pain: Results from the Rule Out Myocardial Infarction by Computed Tomography (ROMICAT) Study (2008) (4)
Composite End Points: Implications of Changing Compositions With Longer Follow-Up (2017) (3)
Short-term effects of cold spells on plasma viscosity: Results from the KORA cohort study in Augsburg, Germany. (2022) (3)
Evaluation of the Metabotype Concept Identified in an Irish Population in the German KORA Cohort Study. (2020) (3)
Augsburg Blood rheology in healthy cigarette smokers. Results from the MONICA project (2011) (3)
Risk Factors, Subsequent Disease Onset, and Prognostic Impact of Myocardial Infarction and Atrial Fibrillation (2022) (3)
Blood lipids and lipoproteins are main determinants of plasma viscosity: Results from the MONICA-project Augsburg (1992) (3)
Supplementary Material 3 (2015) (3)
Prognostic value of long-term trajectories of depression for incident diabetes mellitus in patients with stable coronary heart disease (2021) (3)
Need to Rethink. (2016) (3)
Determinants of Psychotropic Drug Intake in a Metropolitan Population (1986) (3)
Recent developments in cardiovascular risk assessment: relevance to the nephrologist. (2011) (3)
Natriuretic Peptides and Risk of Type 2 Diabetes: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium (2021) (3)
[The reaction of the blood magnesium level in acute and chronic kidney diseases]. (1961) (3)
Prevalence of the Metabolic Syndrome in the Elderly Population According to IDF , WHO , and NCEP Definitions and Associations With C-Reactive Protein (3)
Association of circulating MR-proADM with all-cause and cardiovascular mortality in the general population: Results from the KORA F4 cohort study (2022) (3)
Darapladib for the treatment of cardiovascular disease (2015) (3)
Expression of intercellular adhesion molecule-1 in human coronary endothelial and smooth muscle cells after stimulation with tumor necrosis factor-α (1998) (3)
Chronic Inflammation Mediates the Association between Cortisol and Hyperglycemia: Findings from the Cross-Sectional Population-Based KORA Age Study (2021) (3)
Prognostic impact of acute pulmonary triggers in patients with takotsubo syndrome: new insights from the International Takotsubo Registry (2021) (3)
Supplementary Material 6 (2014) (3)
Prevention of cardiovascular disease guided by total risk estimations - challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy. (2012) (3)
Effect of Angiotensin‐Converting Enzyme Inhibition on Human Tissue Renin (1991) (3)
Presence of Fatty Liver and the Relationship between Alcohol Consumption and Markers of Inflammation (2015) (3)
C-Reactive Protein and Other Inflammatory Markers in Cardiovascular Disease (2007) (3)
CD 14 C (-260 ) 3 T Polymorphism , Plasma Levels of the Soluble Endotoxin Receptor CD 14 , Their Association With Chronic Infections and Risk of Stable Coronary Artery Disease (2016) (3)
Supplementary Material 5 (2014) (3)
Risk-guided therapy: a first step to personalized medicine (2012) (3)
Association of maternal uric acid and cystatin C serum concentrations with maternal and neonatal cardiovascular risk markers and neonatal body composition: The Ulm SPATZ Health Study (2018) (3)
Supplementary Material 7 (2014) (3)
Muscular Strength is Independently Associated with Cystatin C: The KORA-Age Study (2018) (3)
Erratum. Association Between Long-term Exposure to Air Pollution and Biomarkers Related to Insulin Resistance, Subclinical Inflammation, and Adipokines. Diabetes 2016;65:3314–3326 (2017) (3)
Clinical assessment, platelet reactivity measurement or genetic testing after acute coronary syndrome? What benefits the patient? (2013) (3)
Right ventricular function assessed by tissue Doppler echocardiography in older subjects without evidence for structural cardiac disease (2017) (3)
Is measuring endothelial function a good idea for prediction of coronary heart disease complications? (2002) (3)
6 MONTHLY INCLISIRAN AND ATHEROGENIC LIPOPROTEIN REDUCTIONS IN ORION-11 (2020) (2)
Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve implantation (2018) (2)
Relationship between cardiac biomarker concentrations and long-term mortality in subjects with osteoarthritis (2020) (2)
Lipoprotein-Associated Phospholipase A 2 Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population (2004) (2)
Risk prediction by non-invasive coronary imaging: we are not there yet! (2018) (2)
Association of serum uromodulin with adipokines in dependence of type 2 diabetes. (2021) (2)
TOOTH LOSS IS HIGHLY PREVALENT AND ASSOCIATED WITH CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CHRONIC CORONARY HEART DISEASE IN THE GLOBAL STABILITY TRIAL (2013) (2)
Hyperfibrinogenemia and cardiovascular risk: possible strategies for intervention (1996) (2)
Evaluation of left and right ventricular systolic and diastolic electromechanical synchrony in older people: a population-based observational study. (2017) (2)
Lipoprotein(a) and cardiometabolic diseases: the mystery continues. (2010) (2)
Metabolite profiling as a future tool in the prediction of type 2 diabetes mellitus * (2012) (2)
The Longer, the Better? An Empirical Study of the Extent and Mechanisms of Attenuating Biomarker Associations in Cardiovascular Patient Cohorts. (2017) (2)
Sympathetic nervous system: a crucial player modulating residual cardiovascular risk. (2013) (2)
Reply to Letter Regarding Article, “High-Sensitivity Troponin T Concentrations in Acute Chest Pain Patients Evaluated With Cardiac Computed Tomography” (2011) (2)
Echocardiographic B-mode evaluation of the right heart in older people: The ActiFE Study. (2016) (2)
Vitamin E supplementation is associated with lower levels of C-reactive protein only in higher dosages and combined with other antioxidants : The Cooperative Health Research in the Region of Augsburg ( KORA ) F 4 study (2015) (2)
Helicobacter pylori seropositive subjects do not show a pronounced systemic inflammatory response even in the presence of the interleukin-1 receptor antagonist gene polymorphism (2004) (2)
Vasoregulatorypeptidespro-endothelin-1 andpro-adrenomedullin are associated with metabolic syndrome in the population-based KORA F 4 study (2012) (2)
Secukinumab Reduces Endothelial Dysfunction in Subjects with Moderate-to-Severe Plaque Psoriasis Over 52 Weeks: Results of the Exploratory CARIMA Study (2018) (2)
[Diagnosis after recent myocardial infarct]. (2008) (2)
EVALUATION OF LDL-C REDUCTIONS BY SIRNA TREATMENT WITH INCLISIRAN IN PATIENTS WITH DIABETES MELLITUS, METABOLIC SYNDROME OR NEITHER (2020) (2)
Association of proinsulin and hepatic steatosis in a random, population-based sample. (2013) (2)
Short-Term Variation of Inflammatory Markers in Chronic Obstructive Pulmonary Disease (COPD) Patients (2008) (2)
[Suspected acute coronary syndrome in patients without ST-elevation. Exclusion of infarction, early clinical estimation and non-coronary diagnoses]. (2002) (2)
F83. Regular leisure time physical activity and reduced incidence in coronary heart disease: Which mechanisms are involved? Potential role of plasma viscosity (1995) (2)
Is elevated cystatin C a predictor of cardiovascular risk in elderly people without chronic kidney disease? (2007) (2)
Lipoprotein-Associated Phospholipase A 2 and Other Lipid-Related Biomarkers in Cardiovascular Disease (2006) (2)
EFFECT OF INCLISIRAN ON LDL-C REDUCTION ACROSS DIFFERENT BACKGROUND LIPID LOWERING TREATMENTS: ANALYSES FROM ORION-11 (2020) (2)
Pooled safety and efficacy of inclisiran in patients with statin intolerance (ORION-10 and ORION-11) (2020) (2)
Adding Genetic Markers to Classic Risk Factors - An Enhanced Coronary Risk Score Based on the Morgam Prospective Cohorts (2011) (2)
Combining cholesterol-lowering strategies with imaging data: a visible benefit? (2018) (2)
Growth Differentiation Factor-15 as a Potent Predictor of Long-Term Mortality among Subjects with Osteoarthritis (2020) (2)
Assessment of the association of exposure to polycyclic aromatic hydrocarbons, oxidative stress, and inflammation: A cross-sectional study in Augsburg, Germany. (2022) (2)
Comparison of genetic risk prediction models to improve prediction of coronary heart disease in two large cohorts of the MONICA/KORA study (2021) (2)
Prevalence and Prognostic Value of Psychological Stress Events in Patients with First Myocardial Infarction—Long-Term Follow-Up Study (2021) (1)
Proximal left anterior descending coronary heart disease and complex ventricular arrhythmias (1983) (1)
EFFECT OF LONGER-TERM ADMINISTRATION OF EVOLOCUMAB IN PATIENTS WITH ANGIOGRAPHIC CORONARY ARTERY DISEASE: RESULTS OF THE GLAGOV OPEN LABELLED EXTENSION STUDY (2020) (1)
Global cardiovascular risk assessment: improving strategies in patients at intermediate risk. (2003) (1)
C-reactive protein and social status (2001) (1)
Clinical imaging for prevention: Directed strategies for improved detection of presymptomatic patients with undetected atherosclerosis (2008) (1)
OP X – 5 Long-term exposure to air pollution and biomarkers of inflammation and insulin resistance in a longitudinal setting (2018) (1)
Biomarkers for mortality and cardiovascular events. (2005) (1)
Diabetes Mellitus And Cardiovascular Risk In Patients With Chronic Coronary Heart Disease (2016) (1)
Coronary CT angiography for acute chest pain. (2012) (1)
Abstract 18682: Inflammatory Biomarkers for Prognostication of Outcomes in Stable Coronary Artery Disease - Experiences From the STABILITY Trial (2014) (1)
[Electrocardiography and quantitative levocardiography in chronic transmural infarct. A correlative study]. (2008) (1)
Depletion of Homeostatic Antibodies against Malondialdehyde-Modified Low-Density Lipoprotein Correlates with Adverse Events in Major Vascular Surgery (2022) (1)
Inter-individual variability in LDL-C reductions with inclisiran – data from ORION-10 and ORION-11 (2020) (1)
Supplementary Material 9 (2013) (1)
Is twice better than once?-challenges of troponin measurements for risk prediction in the general population. (2019) (1)
Association of C-Terminal Pro-Endothelin-1 with Mortality in the Population-Based KORA F4 Study (2022) (1)
Supplementary Material 15 (2013) (1)
TCT-337 Prognostic value of high-sensitivity cardiac troponin T and gender differences in patients undergoing elective percutaneous coronary intervention. (2016) (1)
S21.4: Gender differences in the relation of body composition parameters to markers of inflammation ‐ Results from the KORA Augsburg Survey 2000 (2004) (1)
Fasting time and lipid parameters: association with hepatic steatosis — data from a random population sample (2014) (1)
C-reactive protein and atherosclerosis: quo vadis? (2001) (1)
Tooth Loss Is Independently Associated With Adverse Outcome But Not Myocardial Infarction In Patients With Chronic Coronary Heart Disease (2015) (1)
Comparison of once daily felodipine 10 mg ER and hydrochlorothiazide 25 mg in the treatment of mild to moderate hypertension (2004) (1)
Dataset of the associations of aldosterone to renin ratio with MR-proANP and MR-proADM (2016) (1)
Inclisiran reduces LDL-cholesterol independent of genotype in subjects with heterozygous familial hypercholesterolaemia (2020) (1)
[Significance of the E point-septum distance for the evaluation of left ventricular function in coronary disease--a study using M-mode echocardiography]. (1983) (1)
Clinical studies in CKD (2012) (1)
Associations of the vasoactive peptides CT-proET-1 and MR-proADM with incident type 2 diabetes: results from the BiomarCaRE Consortium (2022) (1)
Erratum: Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height ((The American Journal of Human Genetics (2010) 88 (6-18)) (2012) (1)
Abstract 2763: Predictive Value of Ankle-Brachial-Index and Plaques in the Carotid and Femoral Arteries on Cardiovascular Events and Mortality in a Population-Based Study with 13-Years of Follow-Up (2006) (1)
C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOV (2020) (1)
[Atherosclerosis: immunological reply to the wrong address?]. (2002) (1)
Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample (2014) (1)
Abstract 10337: Adding Natriuretic Peptides to Either Conventional or High-Sensitivity Troponin-T Improves Reclassification of Acute Coronary Syndrome Diagnosis in Emergency Department Patients with Chest Pain: From the ROMICAT Trial (2011) (1)
[Lipid-lowering therapy in Europe and the United States - treat to target or fire and forget?]. (2016) (1)
Variability of fibrinogen measurements in post-myocardial infarction patients (2012) (1)
Abstract 16427: Efficacy and Safety of Inclisiran According to Age: A Pooled Analysis of Phase III Studies (ORION 9, 10 and 11) (2020) (1)
Air Pollution and Inflammation: Gene-Environment Interactions in Myocardial Infarction Survivors (2009) (1)
Smoking and blood rheology. (1990) (1)
Abstract 1675: Adipokines and Coronary Heart Disease: Results From the Monica/Kora Augsburg Case-cohort Study, 1984-2002 (2009) (1)
Plasma viscosity and hemoglobin in the presence of cardiovascular risk factors (2016) (1)
Associations of carotid intima media thickness with gene expression in whole blood and genetically predicted gene expression across 48 tissues. (2021) (1)
Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the justification for the Use of Statins in Prevention: An Intervention, Trial Evaluating Rosuvastatin Trial (2009) (1)
The Associations of Diuretics and Laxatives Use with Cardiovascular Mortality. An Individual Patient-Data Meta-analysis of Two Large Cohort Studies (2019) (1)
Consumption of Green Vegetables, GSTM1 Genotype and the Association of Air Pollution with Inflammatory Responses (2009) (1)
Effect of obesity on the associations of 25-hydroxyvitamin D with prevalent and incident distal sensorimotor polyneuropathy: population-based KORA F4/FF4 study (2022) (1)
[Qualitative and quantitative analysis of regional contraction disorders using levocardiograms]. (1983) (1)
Abstract 1808: Duffy Antigen Receptor for Chemokines (Darc) Polymorphism Regulates Circulating Concentrations of Monocyte Chemoattractant Protein-1 and Other Circulating Inflammatory Mediators (2009) (1)
Repeated Measurements of Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Assess Long-Term Mortality Risk in Subjects with Osteoarthritis (2021) (1)
Abstract 21: Deciphering the Plasma Proteome of Type 2 Diabetes (2020) (1)
Social Fate after Aorto-Coronary Bypass Surgery (1985) (1)
Increased concentrations of soluble ST2 independently predict cardiac and total mortality but not non-fatal cardiovascular events in stable coronary heart disease patients. (2017) (1)
Abstract 16311: Efficacy and Safety of Inclisiran According to Sex: A Pooled Analysis of the ORION 9, 10 and 11 Trials (2020) (1)
Interleukin-17 in atherosclerosis: Still a long road ahead. (2016) (1)
Mediterranean Diet and Inflammatory Response in Myocardial Infarction Survivors in the AIRGENE Project (2007) (1)
Association of renin and aldosterone with glucose metabolism in a Western European population: the KORA F4/FF4 study (2022) (1)
[Effect of molsidomine on rheological parameters and the incidence of cardiovascular events]. (2003) (1)
Improved cardiovascular risk prediction using plasma proteomics in primary prevention (2020) (1)
Potential sex differences in human milk leptin and their association with asthma and wheeze phenotypes: Results of the Ulm Birth Cohorts (2021) (1)
Plasma fibrin D-dimer levels and risk of coronary artery disease: results of a large case-control study (2001) (1)
GROWTH DIFFERENTIATION FACTOR-15 (GDF-15) FOR PROGNOSTICATION OF OUTCOMES IN STABLE CORONARY ARTERY DISEASE: EXPERIENCES FROM THE STABILITY TRIAL (2015) (1)
Supplementary Material 4 (2015) (1)
Physical Activity and Sex Hormone-Binding Globulin in Older Adults. (2019) (1)
Causal Effects of Adiposity on Cardiovascular Risk Factors (2015) (1)
The role of adiposity in cardiometabolic traits (2013) (1)
Loci influencing blood pressure identified using a cardiovascular gene-centric array (Correction to Ganesh et al. 22 (8): 1663) (2013) (1)
Abstract 407: Rapid Effect of Single Dose Rosiglitazone Treatment on Endothelial Function in Healthy Men with Normal Glucose Tolerance: Data from a Randomized, Placebo-Controlled, Double-Blind Study (2008) (1)
Evaluation of the causal effect of fibrinogen on incident coronary heart disease via Mendelian randomization (2018) (1)
HSCRP PREDICTS MORTALITY BEYOND TROPONIN IN 102,337 PATIENTS WITH SUSPECTED ACUTE CORONARY SYNDROME IN THE UK NATIONAL INSTITUTE FOR HEALTH RESEARCH CRP-RISK STUDY (2019) (0)
TCT-295 Differential Prognostic Value of Galectin-3 According to Levels of Carbohydrate Antigen 125 in Transcatheter Aortic Valve Implantation (2018) (0)
Abstract 15867: Myeloperoxidase Predicts Coronary Heart Disease Independently of Traditional Risk Factors, Inflammatory Markers and Markers of Endothelial Dysfunction: Results from the MONICA/KORA Augsburg Study (2010) (0)
Presentations School of Community Health 1-2019 Cardiovascular Risk Factors Associated With Venous Thromboembolism (2019) (0)
[Reference values in long-term blood pressure measurement]. (1998) (0)
Abstract 1793: Ischemia Modified Albumin Adds Sensitivity to the Initial Workup of Patients with Acute Chest Pain (2007) (0)
Associations between thyroid hormones and serum metabolite profiles in an euthyroid population (2013) (0)
Abstract 17757: Plasma Concentrations of Molecular Lipids are Associated With Coronary Plaque Characteristics and 1-Year Cardiovascular Outcome in Patients With Coronary Artery Disease (2015) (0)
Abstract 1638: Association between Cardiovascular Risk Profiles and the Presence and Extent of Different Types of Coronary Atherosclerotic Plaque as Detected by Multidetector Computed Tomography (2007) (0)
O010 The relationship between intrathoracic fat depots, circulating inflammatory biomarkers and coronary artery disease suggests a local atherogenic effect of the pericoronary adipose tissue compartment (2014) (0)
158. Seasonal variations of hematological, inflammatory and lipid parameters in healthy subjects (1996) (0)
DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases (2016) (0)
The effect of marine n-3 polyunsaturated fatty acids in different doses on lipoprotein-associated phospholipase A2 (2008) (0)
Fibrinogen: Risk Factor or Risk Marker? (1998) (0)
Effect of inclisiran on atherogenic lipoproteins in high-risk primary prevention populations: analysis from the phase III ORION-11 trial (2020) (0)
P2.47: Chronic infection with H pylori and systemic inflammatory response under consideration of the interleukin-1 receptor antagonist gene polymorphism in healthy adults (2004) (0)
THE Q460R MUTATION OF THE ATP SENSITIVE P2X7 ION CHANNEL IS LIKELY TO INFLUENCE TRAUMA-ASSOCIATED HYPERCYTOKINEMIA (2006) (0)
Metabolite profiling reveals new insights into the regulation of serum urate in humans (2013) (0)
P6035The long-term prognostic value of radiofrequency intravascular ultrasound for major adverse cardiovascular events in patients with coronary artery disease during 4.7-years follow-up (2017) (0)
Distribution and Associated Factors of Hepatic Iron—A Population-Based Imaging Study (2021) (0)
[ASA - from cardiovascular to cancer prevention]. (2016) (0)
459 Evaluation of LDL-C reductions by siRNA treatment with inclisiran in patients with diabetes mellitus, metabolic syndrome or neither (2021) (0)
Exercise Capacity, Nt-probnp And Adiponectin In Patients With Acute Coronary Syndrome Before And After Cardiac Rehabilitation As Well As At 12 Months: 1874 (2011) (0)
W14.376 G(-30)A polymorphism in the promoter of the glucokinase gene associated with angiographic coronary artery disease and glucose metabolism (2004) (0)
Darbepoetin alfa in systolic heart failure. (2013) (0)
AIRGENE - AIR POLLUTION AND INFLAMMATORY RESPONSE IN MYOCARDIAL INFARCTION SURVIVORS: GENE-ENVIRONMENT INTERACTION IN A HIGH RISK GROUP (2005) (0)
M-mode echocardiographic findings after successful orthotopic heart transplantation (1988) (0)
ESTIMATED CARDIOVASCULAR BENEFITS OF INCLISIRAN IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (2021) (0)
EFFICACY AND SAFETY OF INCLISIRAN IN PATIENTS WITH CHRONIC KIDNEY DISEASE - A POOLED ANALYSIS FROM THREE PHASE 3 CLINICAL TRIALS (ORION-9, -10 AND -11) (2021) (0)
[Electrocardiogram and M-mode echocardiography in the diagnosis of chronic transmural infarct. Correlations and determination of the accuracy of both methods based on quantitative levocardiography]. (2008) (0)
Plasma concentrations of asymmetric and symmetric dimethyl arginine, secondary cardiovascular events and mortality; results from the KAROLA study (2010) (0)
145 The role of high-sensitivity C-reactive protein in predicting mortality beyond troponin in over 100,000 patients with suspected acute coronary syndrome (NIHR Health Informatics Collaborative CRP-risk Study) (2019) (0)
[Cystatin C and cardiovascular risk]. (2010) (0)
[Age dependency of pulmonary artery pressure after myocardial infarction at rest and during exercise (author's transl)]. (1982) (0)
Abstract 3906: Adiponectin and Risk of Type 2 Diabetes Mellitus in Apparently Healthy Middle-Aged Men From General Population (2006) (0)
Optimized Metabotype Definition Based on a Limited Number of Standard Clinical Parameters in the Population-Based KORA Study (2022) (0)
[Ventricular arrhythmias and left ventricular function in coronary artery disease. A study by M-mode echocardiography and 24-hour Holter-monitoring (author's transl)]. (1981) (0)
The German CaRe High Registry for Familial Hypercholesterolemia –Sex Differences, Treatment Strategies and Target Value Attainment (2022) (0)
Acute Coronary TCT-294 Long Term Outcome of Unprotected Left Main Coronary Artery Disease: Comparison between Coronary Artery Bypass Grafting (CABG) and Percutaneous Coronary Intervention (PCI) Single Center (2018) (0)
Exposure to Environmental Tobacco Smoke and Alcohol Consumption has Short Term Influences on CRP Levels in Myocardial Infarction Survivors (2006) (0)
SELF-REPORTED GENERAL HEALTH AND OUTCOMES IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE: EXPERIENCES FROM THE GLOBAL STABILITY TRIAL (2016) (0)
ASSOCIATION BETWEEN AMBIENT AIR POLLUTION AND BLOOD MARKERS OF INFLAMMATION AND COAGULATION IN INDIVIDUALS WITH POTENTIAL GENETIC PREDISPOSITION ON THE DETOXIFYING PATHWAY (2011) (0)
Caring for patients with normal LDL-C levels Implications of JUPITER results for patients with normal low-density lipoprotein cholesterol and elevated C-reactive protein (2009) (0)
Abstracts of the XV Swedish Cardiovascular Spring Meeting. Göteborg, Sweden. April 17–19, 2013. (2013) (0)
THE EFFECT OF INCLISIRAN IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION: A POST HOC POOLED ANALYSIS FROM THE ORION-10 AND ORION-11 RANDOMIZED CONTROLLED TRIALS (2022) (0)
Baseline triglycerides and non-HDL-C and apoB goal attainment in the ORION-10 and ORION-11 trials (2020) (0)
Association of glycated haemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE consortium (2021) (0)
Erratum to "C-Reactive Protein Levels and Plaque Regression with Evolocumab: Insights From GLAGOV" [American Journal of Preventive Cardiology 3C (2020) 100091]. (2021) (0)
MILANO-PILOT: will infusing HDL mimetics containing apoA-imilano continue to regress coronary atherosclerosis in the modern era of intensive statin therapy? (2017) (0)
Novel biomarkers of inflammation, kidney function and chronic kidney disease in the general population. (2021) (0)
Abstract 18120: High Density Lipoprotein Particles Predict All-cause and Cardiovascular Mortality (2015) (0)
Validation of metabotypes identified in an Irish population in the German KORA FF4 study (2020) (0)
[Mitral valve insufficiency in coronary heart disease]. (1983) (0)
Discovery and replication of SNP-SNP interactions for quantitative lipid traits in over 60,000 individuals (2017) (0)
Abstract 4035: Lipoprotein-Associated Phospholipase A2 Does Not Predict Risk of Incident Type 2 Diabetes Mellitus in Apparently Healthy Middle-Aged Men: A More Specific Marker for Vascular Inflammation? (2006) (0)
Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing (2019) (0)
Abstract 13387: Genetic Variation in the NLRC4 Inflammasome Locus in Relation to Interleukin-18 Concentrations and Cardiovascular Disease (2010) (0)
1P-0246 Helicobacter pylori eradication increases high density lipoproteins (2003) (0)
S23.5: Anxiety and Depression in Patients with Coronary Heart Disease: Prevalence, Prognostic Value and Consideration of Various Pathogenetic Mechanisms (2004) (0)
Association between the fatty liver index and chronic kidney disease: the population-based KORA study. (2022) (0)
Efficacy and Tolerability of Metoprolol Tartrate in Patients with Mild- to- Moderate Essential Hypertension (2001) (0)
Abstract 12243: Associations Between Physical Activity and Prognostic Biomarkers in Patients With Stable Coronary Heart Disease in the STABILITY Trial (2015) (0)
Agreement between four high-sensitivity cardiac troponin assays and non-invasive testing, clinical and quality of care outcomes based on the 2020 ESC guidelines: results from the ROMICAT II trial (2022) (0)
Abstract P173: Serum 25-hydroxyvitamin D and Mortality in Middle-aged Men and Women: Results from the MONICA/KORA Augsburg Study (2012) (0)
Prognostic value of simultaneous assessment of lipid and inflammatory markers in patients with stable coronary heart disease (2003) (0)
Abstract 17392: High-Sensitivity Troponin T Predicts Recurrent Cardiovascular Disease Events in Stable Coronary Heart Disease Patients: 8-Year Follow-Up of the KAROLA Study (2011) (0)
Aalborg Universitet Lipoprotein ( a ) and the risk of cardiovascular disease in the European population (2017) (0)
[Antibiotic treatment in myocardial infarction?]. (2001) (0)
Noninvasive Assessment of Atherosclerosis : From Structure to Function (2006) (0)
[Significance of pulmonary artery diastolic pressure after myocardial infarction for physical training (author's transl)]. (1978) (0)
Markers of oxidative stress and risk of type 2 diabetes mellitus: Results from the MONICA/KORA Augsburg Study 1984–2002 (2010) (0)
Abstract P285: Frequency of Sexual Activity the Year before Myocardial Infarction and Risk for Subsequent Cardiovascular Adverse Events: Results of a Long-Term Follow-Up Study (2015) (0)
Apparent Temperature and Inflammatory Markers in a European Panel Study (2006) (0)
TREATMENT of hypertension. (1954) (0)
Abstract 17360: Genome-Wide Meta-Analysis of Plasminogen Activator Inhibitor Type 1 (PAI-1) Identifies a New Locus Independent of the Serpine1 4G/5G Polymorphism (2010) (0)
[Alternatives to balloon angioplasty. Radio frequency angioplasty, directional coronary atherectomy, high frequency rational angioplasty and coronary extraction atherectomy]. (1997) (0)
Abstract MP05: N Terminal Pro B Type Natriuretic Peptide as a Stroke Risk Factor in the European Population: Results From the Biomarcare Consortium (2018) (0)
Clinical Features and Outcomes of Patients With Malignancy (2020) (0)
Assessment of global and regional myocardial function using the Minnesota codes (1993) (0)
S13.5. Hyperfibrinogenemia and cardiovascular risk: Possible strategies for intervention (1995) (0)
Fixed Combinations of Candesartan Cilexetil and Hydrochlorothiazide or Losartan and Hydrochlorothiazide in Patients with Moderate to Severe Hypertension: The Editor (2000) (0)
Genome-wide association and functional follow-up reveals new loci for kidney function | NOVA. The University of Newcastle's Digital Repository (2012) (0)
CALCULATION ERROR AND ANALYTICAL OMISSIONS. AUTHORS' REPLY (1997) (0)
Imaging High-Sensitivity Troponin T Concentrations in Acute Chest Pain Patients Evaluated With Cardiac Computed Tomography (2010) (0)
Epidemiology of Digitalis Use — Results from a Random Sample of the Munich Population (1985) (0)
Reduction of MCP-1 and MIF by a Polyphenol-rich extract in subjects with clustered cardiometabolic risk factors (2011) (0)
Proceedings of the Third International Fibrinogen Symposium Hemostasis, Inflammation and Cardiovascular Disease, May 3-4, 1996, Ulm, Germany (1997) (0)
Oral communications (2006) (0)
O-068: Association between Residential Long-Term Exposure to Air Pollution and Fibrinogen. (2012) (0)
Intima of Early Atherosclerotic Lesions of Human Coronary Arteries C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the (1998) (0)
[Stress in the sense of mental work as a cause of disturbed central hemodynamics in coronary patients]. (1980) (0)
Abstract 3088: Association between Coronary Plaque Burden as Measured by Multidetector Computed Tomography and Inflammatory Biomarkers in Patients with Acute Chest Pain (2007) (0)
Abstract 17135: Serum 25-Hydroxyvitamin D Deficiency Increases Risk of Myocardial Infarction: Results From the Prospective Monica/Kora Augsburg Case-Cohort Study (2011) (0)
New Blood Biomarkers of Inflammation and Atherosclerosis (2011) (0)
Long-term air pollution at residence and urinary albumin excretion (2016) (0)
Persistent inflammatory residual risk despite aggressive cholesterol-lowering therapy: what is next? (2021) (0)
Abstract 17304: Dense Genotyping of Candidate Gene Loci Identifies Variants Associated with Soluble E-Selectin Levels (2011) (0)
Abstract 16978: Midregional Pro-Atrial Natriuretic Peptide and Risk of Recurrent Cardiovascular Disease Events in Patients with Stable Coronary Heart Disease Followed Over 8 Years (2011) (0)
THE RELATIONSHIP BETWEEN TOOTH LOSS, CARDIOVASCULAR BIOMARKERS AND OUTCOMES IN PATIENTS WITH STABLE CORONARY HEART DISEASE (2016) (0)
Sustained elevation of the proinflammatory cytokine IL-6 but not CRP in serum of type 2 diabetes patients with diabetic foot syndrome (2006) (0)
Abstract 13035: Levels of Inflammatory Biomarkers Correlate with Plaque Progression as Measured in Coronary CT Angiography (2011) (0)
Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans (2014) (0)
Validity of the Minnesota Q-QS Code for the detection of chronic myocardial infarction (1989) (0)
[Prescription habits in the long-term treatment with digitalis glycosides]. (1983) (0)
SR1.2. Clinical trials in blood rheology (1995) (0)
Abstract P008: Ultra-Sensitive Troponin I Strongly Predicts Incident Coronary Heart Disease in the General Population Independently of Traditional Risk Factors. Results From the MONICA/KORA Augsburg Case-Cohort Study (2014) (0)
Abstract 11143: Efficacy and Safety of Inclisiran by Baseline Body Mass Index: A Post Hoc Pooled Analysis of the ORION-9, ORION-10 and ORION-11 Phase III Randomized Controlled Trials (2021) (0)
Abstract 5509: Association of Pericardial Adipose Tissue With Coronary Atherosclerotic Plaque and Inflammatory Blood Biomarkers (2009) (0)
Response to Drs. Rasmussen and Pareek regarding our paper in Int. J. Cardiol. 2018; 250: 247-252: Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study. (2018) (0)
Association between subclinical inflammation and painful polyneuropathy in an older population: KORA F4 study (2014) (0)
Does intravenous prostaglandin E (PGE)-therapy change blood rheology in patients with peripheral arterial occlusive disease (PAOD)? (1995) (0)
Influence of assay variability , location and storage time on cytokine measurements in population-based biobanking Cytokine measurements in biobanking (2018) (0)
[Epidemiology of digitalis medication. Results of the Munich blood-pressure study]. (1984) (0)
NT-PROBNP SERUM CONCENTRATIONS IN SURGICAL CRITICALLY ILL PATIENTS WITH NON-SEPTIC AND SEPTIC SHOCK (2013) (0)
Association Between Long-Term Residential Exposure To Air Pollution And Biomarkers Related To Insulin Resistance (2015) (0)
A Common Variant In The Nlrp3 Inflammasome Locus Associates With Mortality (2019) (0)
[Effect of atenolol and nitroglycerin ointment on exertion tolerance in coronary disease]. (2008) (0)
OP X – 3 C-reactive protein (crp) and long-term air pollution with a focus on ultrafine particles (2018) (0)
University of Groningen Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci Tragante, (2014) (0)
Abstract P045: Residential Traffic Exposure and Intima Media Thickness in Augsburg, Germany (2012) (0)
Abstract P206: The Risk for Cardiovascular Disease Attributable to Traditional Risk Factors Increases (2018) (0)
Supplementary data from: Serum uromodulin is associated with but does not predict type 2 diabetes in elderly KORA F4/FF4 study participants (2019) (0)
Lowering Plasma Cholesterol Fenofibrate Reduces Atherogenesis in ApoE * 3 Leiden Mice : Evidence for Multiple (2006) (0)
Associations between Novel Air Pollution Markers and Blood Biomarkers of Inflammation and Coagulation/Fibrinolysis in Three Susceptible Populations (2014) (0)
P2952 Lipoprotein-associated phospholipase A2 and risk of coronary events in apparently healthy middle-aged men with moderately elevated cholesterol: the MONICA-Augsburg cohort study (2003) (0)
Chronic stress exposure in the elderly compromises the non-inflammatory properties of glucocorticoids (2016) (0)
Abstract 4065: Chemokines and Risk of Myocardial Infarction: Results from the MONICA/KORA Augsburg Study, 1984 2002 (2006) (0)
Abstract 11033: Efficacy and Safety of Inclisiran by Baseline Glycemic Status: A Post Hoc Pooled Analysis of the ORION-10 and ORION-11 Phase III Randomized Controlled Trials (2021) (0)
Increased serum levels of interleukin 1 receptor antagonist (IL-1ra) levels precede the onset of coronary heart disease: results from the MONICA/KORA Augsburg study (2016) (0)
Generalized anxiety disorder and incident type 2 diabetes in KORA F4/FF4 study (2019) (0)
Treatment of hypertension (1986) (0)
Prognostic value of chronic kidney disease in patients with coronary heart disease: Role of glomerular filtration rate estimating equations (2010) (0)
Abstract 16755: Association Between Achievement of Risk Factor Standard of Care Goals and Major Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease in the STABILITY Trial (2015) (0)
Summer School "Inflammation and Cardiovascular Disease" (2011) (0)
The vigor of drug treatment in the control of hypertension: results from the Munich Blood Pressure Study. (1985) (0)
Abstract 5023: Correlates of High Sensitivity Troponin T Concentrations in Chest Pain Patients With and Without Acute Coronary Syndrome (2009) (0)
other inflammatory mediators circulating concentrations of monocyte chemoattractant protein-1 and Duffy antigen receptor for chemokines (Darc) polymorphism regulates (2014) (0)
[Computer-aided reading of ECG (author's transl)]. (1979) (0)
E-058: Short-term effects of air temperature on blood markers of coagulation and inflammation in potentially susceptible individuals (2012) (0)
High-Sensitivity Cardiac Troponin Assays—Change Is Important (2012) (0)
3303Classification of patients with acute chest pain by analytical benchmarks and subsequent management recommendations - A comparison of three highly-sensitivity troponin assays in the ROMICAT trials (2019) (0)
Effect Modification of Interleukin-6 Response to Ambient Carbon Monoxide Levels by Fibrinogen and Interleukin-6 Polymorphisms (2008) (0)
Association of smoking with markers of systemic inflammation: results of a population-based study (2002) (0)
Chronic inflammation contributes to cortisol-induced hyperglycemia: Findings from the KORA Age study (2019) (0)
[Lp(a) and its role in cardiovascular diseases]. (2022) (0)
[Hyperfibrinogenemia and cardiovascular risk--epiphenomenon or causal relationship?]. (1995) (0)
[Determinants of plasma digoxin and digitoxin concentrations in elderly patients. A multivariate analysis]. (1987) (0)
Coronary artery disease Low-density lipoprotein particle diameter and mortality : the Ludwigshafen Risk and Cardiovascular Health Study (2015) (0)
8 PROCALCITONIN (PCT) AFTER MAJOR UROLOGICAL PROCEDURES-A USEFUL DIAGNOSTIC TOOL? (2007) (0)
Vitamin D in Relation to Incident Sarcopenia and Changes in Muscle Parameters Among Older Adults: The KORA-Age Study (2019) (0)
Chronic stress exposure in the elderly may compromise the non-inflammatory (2016) (0)
H. pylori cagA, vacA and iceA genotype associations with gastroesophageal reflux disease (GERD) compared to other upper gastrointestinal diseases (2000) (0)
INCREASED CONCENTRATIONS OF SOLUBLE ST2 INDEPENDENTLY PREDICT CARDIAC AND TOTAL MORTALITY BUT NOT NON-FATAL CARDIOVASCULAR EVENTS IN STABLE CORONARY HEART DISEASE PATIENTS: 13-YEAR FOLLOW-UP OF THE KAROLA STUDY (2017) (0)
MP354SYMMETRIC DIMETHYLARGININE, HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE (2017) (0)
Coffee consumption and NAFLD: a community based study on 1223 subjects (2015) (0)
TARGETED PROTEOMICS IMPROVES CARDIOVASCULAR RISK PREDICTION IN SECONDARY PREVENTION PATIENTS (2022) (0)
Best Practice & Research Clinical Endocrinology & Metabolism (2014) (0)
Th-W56:1 Risk stratification in asymptomatic subjects (2006) (0)
OP X – 1 Long-term exposure to ultrafine particles and type 2 diabetes prevalence in a longitudinal setting (2018) (0)
Associations between variations in the TLR4 gene and incident coronary heart disease (CHD) in middle-aged men and women: Results from the MONICA/KORA Augsburg case-cohort study, 1984–2002 (2010) (0)
484 Effect of Longer-Term Administration of Evolocumab in Patients With Angiographic Coronary Artery Disease: Results of the GLAGOV Open Label Extension Study (2020) (0)
Commentaries on Cutting Edge Science (2013) (0)
[Computer-assisted ECG evaluation in polyclinic patients]. (1981) (0)
Abstract 11655: Can Blood Biomarkers Predict Whose Heart is Healthy? - Discriminatory Capacity of High-sensitivity Troponin T and C-reactive Protein Between Patients With and Without Coronary Atherosclerosis, LV Hypertrophy/Dysfunction and Myocardial Perfusion Abnormalities as Assessed by Cardiac CT (2012) (0)
Long-Term Residential Exposure to Ultrafine Particles and C-Reactive Protein (CRP) (2018) (0)
P2.49: Case‐cohort design – a suitable method to evaluate characteristics and associations in the presence of a restricted budget for laboratory analyses (2004) (0)
Clinical Chemistry's Special Issue on Men's Health. (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Wolfgang Koenig?

Wolfgang Koenig is affiliated with the following schools:

Wolfgang Koenig's Academic­Influence.com Rankings

Why Is Wolfgang Koenig Influential?

Wolfgang Koenig's Published Works

Published Works

What Schools Are Affiliated With Wolfgang Koenig?

Wolfgang Koenig's AcademicInfluence.com Rankings